Header Logo

XIFENG WU

TitleProfessor
InstitutionMD Anderson
DepartmentEpidemiology
Address1155 Pressler St
Houston TX 77030-3721
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Wu X, Wen CP, Ye Y, Tsai M, Wen C, Roth JA, Pu X, Chow WH, Huff C, Cunningham S, Huang M, Wu S, Tsao CK, Gu J, Lippman SM. Author Correction: Personalized Risk Assessment in Never, Light, and Heavy Smokers in a prospective cohort in Taiwan. Sci Rep. 2020 Mar 23; 10(1):5514. PMID: 32251345; PMCID: PMC7090032.
      Citations:    Fields:    
    2. Wu X, Hildebrandt MA, Ye Y, Chow WH, Gu J, Cunningham S, Zhao H, Hawk ET, Wagar E, Rodriguez A, Hamilton SR. Cohort Profile: The MD Anderson Cancer Patients and Survivors Cohort (MDA-CPSC). Int J Epidemiol. 2016 06; 45(3):713-713f. PMID: 26686840; PMCID: PMC5841601.
      Citations: 10     Fields:    Translation:Humans
    3. Melkonian SC, Daniel CR, Ye Y, Tannir NM, Karam JA, Matin SF, Wood CG, Wu X. Gene-environment interaction of genome-wide association study-identified susceptibility loci and meat-cooking mutagens in the etiology of renal cell carcinoma. Cancer. 2016 Jan 01; 122(1):108-15. PMID: 26551148; PMCID: PMC5016565.
      Citations: 13     Fields:    Translation:Humans
    4. Pierzynski JA, Hildebrandt MA, Kamat AM, Lin J, Ye Y, Dinney CP, Wu X. Genetic Variants in the Wnt/?-Catenin Signaling Pathway as Indicators of Bladder Cancer Risk. J Urol. 2015 Dec; 194(6):1771-6. PMID: 26173102; PMCID: PMC5087323.
      Citations: 24     Fields:    Translation:HumansCells
    5. Machiela MJ, Zhou W, Sampson JN, Dean MC, Jacobs KB, Black A, Brinton LA, Chang IS, Chen C, Chen C, Chen K, Cook LS, Crous Bou M, De Vivo I, Doherty J, Friedenreich CM, Gaudet MM, Haiman CA, Hankinson SE, Hartge P, Henderson BE, Hong YC, Hosgood HD, Hsiung CA, Hu W, Jessop L, Kim HN, Kim YH, Kim YT, Klein R, Kraft P, Lan Q, Lin D, Liu J, Le Marchand L, Liang X, Lissowska J, Lu L, Magliocco AM, Matsuo K, Olson SH, Orlow I, Park JY, Prescott J, Rastogi R, Risch HA, Schumacher F, Seow A, Setiawan VW, Shen H, Shin MH, Shu XO, VanDen Berg D, Wang JC, Wentzensen N, Wong MP, Wu C, Wu T, Wu YL, Yang HP, Yang PC, Zheng W, Abnet CC, Albanes D, Aldrich MC, Amos C, Amundadottir LT, Berndt SI, Blot WJ, Bock CH, Bracci PM, Burdett L, Buring JE, Butler MA, Chatterjee N, Chung CC, Cook MB, Cullen M, Davis FG, Ding T, Duell EJ, Epstein CG, Fan JH, Figueroa JD, Fraumeni JF, Freedman ND, Fuchs CS, Gao YT, Gapstur SM, Garcia-Closas M, Gaziano JM, Giovannucci EL, Goldin L, Goldstein AM, Greene MH, Harris CC, Holly EA, Hoover RN, Hu N, Hutchinson A, Jenab M, Johansen C, Khaw KT, Koh WP, Kolonel LN, Kooperberg C, Krogh V, Kurtz RC, LaCroix A, Landgren A, Landi MT, Li D, Liao LM, Malats N, McGlynn KA, McWilliams RR, Mirabello L, Peters U, Petersen GM, Prokunina-Olsson L, Purdue M, Qiao YL, Rabe KG, Rajaraman P, Riboli E, Rothman N, Ruder AM, Savage SA, Schwartz AG, Schwartz KL, Sesso HD, Silverman DT, Spitz MR, Stevens VL, Stolzenberg-Solomon R, Stram D, Tang ZZ, Taylor PR, Teras LR, Tobias GS, Viswanathan K, Wacholder S, Wang Z, Weinstein SJ, Wheeler W, White E, Wiencke JK, Wolpin BM, Wu X, Wunder JS, Yu K, Zeleniuch-Jacquotte A, Ziegler RG, de Andrade M, Barnes KC, Beaty TH, Bierut LJ, Desch KC, Doheny KF, Feenstra B, Ginsburg D, Heit JA, Kang JH, Laurie CA, Li JZ, Lowe WL, Marazita ML, Melbye M, Murray JC, Nelson SC, Pasquale LR, Rice K, Wiggs JL, Wise A, Tucker M, Laurie CC, Caporaso NE, Yeager M, Chanock SJ, Hunter DJ, Pooler L, Sheng X, Xia L, Zhou B, Carre?n T, Pati?o-Garcia A, Giles GG, Gillanders EM, Hallmans G, Henriksson R, McNeill LH, Melin BS, Peplonska B, Real FX, Rodr?guez-Santiago B, Severi G, Zanetti KA, Mirel DB, P?rez-Jurado LA. Characterization of large structural genetic mosaicism in human autosomes. Am J Hum Genet. 2015 Mar 05; 96(3):487-97. PMID: 25748358; PMCID: PMC4375431.
      Citations: 63     Fields:    Translation:Humans
    6. Sun W, Wen CP, Lin J, Wen C, Pu X, Huang M, Tsai MK, Tsao CK, Wu X, Chow WH. ABO blood types and cancer risk--a cohort study of 339,432 subjects in Taiwan. Cancer Epidemiol. 2015 Apr; 39(2):150-6. PMID: 25600007; PMCID: PMC4993100.
      Citations: 16     Fields:    Translation:Humans
    7. Liu X, Meng QH, Ye Y, Hildebrandt MA, Gu J, Wu X. Prognostic significance of pretreatment serum levels of albumin, LDH and total bilirubin in patients with non-metastatic breast cancer. Carcinogenesis. 2015 Feb; 36(2):243-8. PMID: 25524924.
      Citations: 55     Fields:    Translation:Humans
    8. Melkonian SC, Wang X, Gu J, Matin SF, Tannir NM, Wood CG, Wu X. Mitochondrial DNA copy number in peripheral blood leukocytes and the risk of clear cell renal cell carcinoma. Carcinogenesis. 2015 Feb; 36(2):249-55. PMID: 25524925; PMCID: PMC4322190.
      Citations: 12     Fields:    Translation:HumansCells
    9. Lin J, Blalock JA, Chen M, Ye Y, Gu J, Cohen L, Cinciripini PM, Wu X. Depressive symptoms and short telomere length are associated with increased mortality in bladder cancer patients. Cancer Epidemiol Biomarkers Prev. 2015 Feb; 24(2):336-43. PMID: 25416716; PMCID: PMC4332382.
      Citations: 13     Fields:    Translation:HumansCells
    10. Wen CP, Zhang F, Liang D, Wen C, Gu J, Skinner H, Chow WH, Ye Y, Pu X, Hildebrandt MA, Huang M, Chen CH, Hsiung CA, Tsai MK, Tsao CK, Lippman SM, Wu X. The ability of bilirubin in identifying smokers with higher risk of lung cancer: a large cohort study in conjunction with global metabolomic profiling. Clin Cancer Res. 2015 Jan 01; 21(1):193-200. PMID: 25336700; PMCID: PMC4286447.
      Citations: 21     Fields:    Translation:Humans
    11. Zhang J, Fujimoto J, Zhang J, Wedge DC, Song X, Zhang J, Seth S, Chow CW, Cao Y, Gumbs C, Gold KA, Kalhor N, Little L, Mahadeshwar H, Moran C, Protopopov A, Sun H, Tang J, Wu X, Ye Y, William WN, Lee JJ, Heymach JV, Hong WK, Swisher S, Wistuba II, Futreal PA. Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing. Science. 2014 Oct 10; 346(6206):256-9. PMID: 25301631; PMCID: PMC4354858.
      Citations: 432     Fields:    Translation:Humans
    12. Skinner HD, Lee JH, Bhutani MS, Weston B, Hofstetter W, Komaki R, Shiozaki H, Wadhwa R, Sudo K, Elimova E, Song S, Ye Y, Huang M, Ajani J, Wu X. A validated miRNA profile predicts response to therapy in esophageal adenocarcinoma. Cancer. 2014 Dec 01; 120(23):3635-41. PMID: 25091571; PMCID: PMC4239178.
      Citations: 30     Fields:    Translation:Humans
    13. Pu X, Wang L, Chang JY, Hildebrandt MA, Ye Y, Lu C, Skinner HD, Niu N, Jenkins GD, Komaki R, Minna JD, Roth JA, Weinshilboum RM, Wu X. Inflammation-related genetic variants predict toxicity following definitive radiotherapy for lung cancer. Clin Pharmacol Ther. 2014 Nov; 96(5):609-15. PMID: 25054431; PMCID: PMC4206576.
      Citations: 13     Fields:    Translation:Humans
    14. Melkonian SC, Daniel CR, Hildebrandt MA, Tannir NM, Ye Y, Chow WH, Wood CG, Wu X. Joint association of genome-wide association study-identified susceptibility loci and dietary patterns in risk of renal cell carcinoma among non-Hispanic whites. Am J Epidemiol. 2014 Sep 01; 180(5):499-507. PMID: 25053674; PMCID: PMC4143080.
      Citations: 8     Fields:    Translation:Humans
    15. Stewart DJ, Chang DW, Ye Y, Spitz M, Lu C, Shu X, Wampfler JA, Marks RS, Garces YI, Yang P, Wu X. Wnt signaling pathway pharmacogenetics in non-small cell lung cancer. Pharmacogenomics J. 2014 Dec; 14(6):509-22. PMID: 24980784; PMCID: PMC4237616.
      Citations: 25     Fields:    Translation:HumansCells
    16. Sun Y, Gu J, Ajani JA, Chang DW, Wu X, Stroehlein JR. Genetic and intermediate phenotypic susceptibility markers of gastric cancer in Hispanic Americans: a case-control study. Cancer. 2014 Oct 01; 120(19):3040-8. PMID: 24962126.
      Citations: 17     Fields:    Translation:HumansCells
    17. Wang Y, McKay JD, Rafnar T, Wang Z, Timofeeva MN, Broderick P, Zong X, Laplana M, Wei Y, Han Y, Lloyd A, Delahaye-Sourdeix M, Chubb D, Gaborieau V, Wheeler W, Chatterjee N, Thorleifsson G, Sulem P, Liu G, Kaaks R, Henrion M, Kinnersley B, LeCalvez-Kelm F, Stevens VL, Gapstur SM, Chen WV, Zaridze D, Szeszenia-Dabrowska N, Lissowska J, Rudnai P, Mates D, Bencko V, Foretova L, Janout V, Krokan HE, Gabrielsen ME, Skorpen F, Vatten L, Chen C, Goodman G, Benhamou S, Vooder T, Nelis M, Metspalu A, Lener M, Lubinski J, Johansson M, Vineis P, Agudo A, Bueno-de-Mesquita HB, Trichopoulos D, Khaw KT, Riboli E, Lathrop M, Scelo G, Albanes D, Caporaso NE, Ye Y, Gu J, Wu X, Spitz MR, Dienemann H, Su L, Matakidou A, Eisen T, Stefansson K, Risch A, Chanock SJ, Christiani DC, Hung RJ, Brennan P, Landi MT, Houlston RS, Amos CI, Vall?e M, Fabianova E, Nj?lstad I, V?lk K, Clavel-Chapelon F, Johansson M, Weiderpass E, Tj?nneland A, Rosenberger A. Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer. Nat Genet. 2014 Jul; 46(7):736-41. PMID: 24880342; PMCID: PMC4074058.
      Citations: 181     Fields:    Translation:Humans
    18. Saxena R, Bjonnes A, Prescott J, Dib P, Natt P, Lane J, Lerner M, Cooper JA, Ye Y, Li KW, Codd V, Brackett D, Mirabello L, Kraft P, Dinney CP, Stowell D, Peyton M, Ralhan S, Wander GS, Mehra NK, Salpea KD, Gu J, Wu X, Mangino M, Hunter DJ, De Vivo I, Humphries SE, Samani NJ, Spector TD, Savage SA, Sanghera DK, Maubaret CG. Genome-wide association study identifies variants in casein kinase II (CSNK2A2) to be associated with leukocyte telomere length in a Punjabi Sikh diabetic cohort. Circ Cardiovasc Genet. 2014 Jun; 7(3):287-95. PMID: 24795349; PMCID: PMC4106467.
      Citations: 23     Fields:    Translation:HumansCells
    19. Pu X, Hildebrandt MA, Lu C, Roth JA, Stewart DJ, Zhao Y, Heist RS, Ye Y, Chang DW, Su L, Minna JD, Lippman SM, Spitz MR, Christiani DC, Wu X. Inflammation-related genetic variations and survival in patients with advanced non-small cell lung cancer receiving first-line chemotherapy. Clin Pharmacol Ther. 2014 Sep; 96(3):360-369. PMID: 24755914; PMCID: PMC4141040.
      Citations: 13     Fields:    Translation:Humans
    20. Tan W, Gu J, Huang M, Wu X, Hildebrandt MA. Epigenetic analysis of microRNA genes in tumors from surgically resected lung cancer patients and association with survival. Mol Carcinog. 2015 Jun; 54 Suppl 1:E45-51. PMID: 24665010; PMCID: PMC4814160.
      Citations: 5     Fields:    Translation:HumansCells
    21. Sanchez-Espiridion B, Chen M, Chang JY, Lu C, Chang DW, Roth JA, Wu X, Gu J. Telomere length in peripheral blood leukocytes and lung cancer risk: a large case-control study in Caucasians. Cancer Res. 2014 May 01; 74(9):2476-86. PMID: 24618342; PMCID: PMC4357479.
      Citations: 44     Fields:    Translation:HumansCells
    22. Coscio A, Chang DW, Roth JA, Ye Y, Gu J, Yang P, Wu X. Genetic variants of the Wnt signaling pathway as predictors of recurrence and survival in early-stage non-small cell lung cancer patients. Carcinogenesis. 2014 Jun; 35(6):1284-91. PMID: 24517998; PMCID: PMC4043238.
      Citations: 8     Fields:    Translation:HumansCells
    23. Wu X, Zheng YL, Hsu TC. Mutagen sensitivity as measured by induced chromatid breakage as a marker of cancer risk. Methods Mol Biol. 2014; 1105:183-92. PMID: 24623229.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    24. Ye Y, Calle ML, Rothman N, Petrus S, Chanock SJ, Carrato A, Silverman DT, Wu X, de Maturana EL, Urrea V, Kogevinas M, Tard?n A, Garc?a-Closas M, Gonz?lez-Neira A, Vellalta G, Navarro A, Lorente-Gald?s B, Real FX, Malats N. Application of multi-SNP approaches Bayesian LASSO and AUC-RF to detect main effects of inflammatory-gene variants associated with bladder cancer risk. PLoS One. 2013; 8(12):e83745. PMID: 24391818; PMCID: PMC3877090.
      Citations: 9     Fields:    Translation:Humans
    25. Wang Y, Ye Y, Lin J, Meyer L, Wu X, Lu K, Liang D. Genetic variants in matrix metalloproteinase genes as disposition factors for ovarian cancer risk, survival, and clinical outcome. Mol Carcinog. 2015 Jun; 54(6):430-9. PMID: 25867973; PMCID: PMC4869714.
      Citations: 5     Fields:    Translation:Humans
    26. Purdue MP, Ye Y, Wang Z, Colt JS, Schwartz KL, Davis FG, Rothman N, Chow WH, Wu X, Chanock SJ. A genome-wide association study of renal cell carcinoma among African Americans. Cancer Epidemiol Biomarkers Prev. 2014 Jan; 23(1):209-14. PMID: 24220910; PMCID: PMC3901793.
      Citations: 11     Fields:    Translation:Humans
    27. Wagner KW, Alam H, Dhar SS, Giri U, Li N, Wei Y, Giri D, Cascone T, Kim JH, Ye Y, Multani AS, Chan CH, Erez B, Saigal B, Chung J, Lin HK, Wu X, Hung MC, Heymach JV, Lee MG. KDM2A promotes lung tumorigenesis by epigenetically enhancing ERK1/2 signaling. J Clin Invest. 2013 Dec; 123(12):5231-46. PMID: 24200691; PMCID: PMC3859406.
      Citations: 81     Fields:    Translation:HumansAnimalsCells
    28. Earp MA, Kelemen LE, Magliocco AM, Swenerton KD, Chenevix-Trench G, Australian Cancer Study, Australian Ovarian Cancer Study Group, Lu Y, Hein A, Ekici AB, Beckmann MW, Fasching PA, Lambrechts D, Despierre E, Vergote I, Lambrechts S, Doherty JA, Rossing MA, Chang-Claude J, Rudolph A, Friel G, Moysich KB, Odunsi K, Sucheston-Campbell L, Lurie G, Goodman MT, Carney ME, Thompson PJ, Runnebaum IB, Hillemanns P, Antonenkova N, Bogdanova N, Leminen A, Nevanlinna H, Pelttari LM, Butzow R, Bunker CH, Modugno F, Edwards RP, Ness RB, du Bois A, Heitz F, Schwaab I, Harter P, Karlan BY, Walsh C, Lester J, Jensen A, Lundvall L, Sellers TA, Fridley BL, Goode EL, Cunningham JM, Vierkant RA, Giles GG, Baglietto L, Severi G, Southey MC, Liang D, Wu X, Lu K, Hildebrandt MA, Levine DA, Bisogna M, Schildkraut JM, Iversen ES, Weber RP, Berchuck A, Cramer DW, Terry KL, Poole EM, Tworoger SS, Bandera EV, Chandran U, Orlow I, Olson SH, Wik E, Salvesen HB, Bjorge L, Halle MK, van Altena AM, Aben KK, Kiemeney LA, Massuger LF, Pejovic T, Bean YT, Cybulski C, Gronwald J, Lubinski J, Wentzensen N, Brinton LA, Lissowska J, Garcia-Closas M, Dicks E, Dennis J, Easton DF, Song H, Tyrer JP, Pharoah PD, Eccles D, Campbell IG, Whittemore AS, McGuire V, Sieh W, Rothstein JH, Flanagan JM, Paul J, Brown R, Phelan CM, Risch HA, McLaughlin JR, Narod SA, Ziogas A, Anton-Culver H, Gentry-Maharaj A, Menon U, Gayther SA, Ramus SJ, Wu AH, Pearce CL, Pike MC, Dansonka-Mieszkowska A, Rzepecka IK, Szafron LM, Kupryjanczyk J, Cook LS, Le ND, Brooks-Wilson A, Ovarian Cancer Association Consortium, D?rst M, D?rk T, Kj?r SK, H?gdall CK, H?gdall E. Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. Hum Genet. 2014 May; 133(5):481-97. PMID: 24190013; PMCID: PMC4063682.
      Citations: 12     Fields:    Translation:Humans
    29. Figueroa JD, Ye Y, Siddiq A, Garcia-Closas M, Chatterjee N, Prokunina-Olsson L, Cortessis VK, Kooperberg C, Cussenot O, Benhamou S, Prescott J, Porru S, Dinney CP, Baris D, Purdue M, Jacobs EJ, Albanes D, Wang Z, Deng X, Chung CC, Tang W, Bas Bueno-de-Mesquita H, Trichopoulos D, Weiderpass E, Krogh V, Dorronsoro M, Travis R, Brenan P, Chang-Claude J, Riboli E, Conti D, Gago-Dominguez M, Stern MC, Pike MC, Van Den Berg D, Yuan JM, Hohensee C, Rodabough R, Cancel-Tassin G, Roupret M, Comperat E, Chen C, De Vivo I, Giovannucci E, Hunter DJ, Kraft P, Lindstrom S, Carta A, Pavanello S, Arici C, Mastrangelo G, Kamat AM, Lerner SP, Barton Grossman H, Lin J, Gu J, Pu X, Hutchinson A, Burdette L, Wheeler W, Kogevinas M, Serra C, Carrato A, Lloreta J, Schwenn M, Karagas MR, Johnson A, Schned A, Armenti KR, Hosain GM, Andriole G, Grubb R, Black A, Ryan Diver W, Gapstur SM, Weinstein SJ, Virtamo J, Haiman CA, Landi MT, Caporaso N, Fraumeni JF, Vineis P, Wu X, Silverman DT, Chanock S, Rothman N, Malats N, Ljungberg B, Clavel-Chapelon F, Tj?nneland A, Tard?n A, Garc?a-Closas R. Genome-wide association study identifies multiple loci associated with bladder cancer risk. Hum Mol Genet. 2014 Mar 01; 23(5):1387-98. PMID: 24163127; PMCID: PMC3919005.
      Citations: 74     Fields:    Translation:Humans
    30. Pu X, Ye Y, Wu X. Development and validation of risk models and molecular diagnostics to permit personalized management of cancer. Cancer. 2014 Jan 01; 120(1):11-9. PMID: 24114238.
      Citations: 8     Fields:    Translation:Humans
    31. Bau DT, Lippman SM, Xu E, Gong Y, Lee JJ, Wu X, Gu J. Short telomere lengths in peripheral blood leukocytes are associated with an increased risk of oral premalignant lesion and oral squamous cell carcinoma. Cancer. 2013 Dec 15; 119(24):4277-83. PMID: 24105340; PMCID: PMC3855186.
      Citations: 16     Fields:    Translation:HumansCells
    32. Xu E, Gu J, Hawk ET, Wang KK, Lai M, Huang M, Ajani J, Wu X. Genome-wide methylation analysis shows similar patterns in Barrett's esophagus and esophageal adenocarcinoma. Carcinogenesis. 2013 Dec; 34(12):2750-6. PMID: 23996928; PMCID: PMC3845893.
      Citations: 21     Fields:    Translation:HumansCells
    33. Gong Y, Ye Y, Lin J, Chang DW, Kamat AM, Wu X, Fern?ndez MI. ?-H2AX level in peripheral blood lymphocytes as a risk predictor for bladder cancer. Carcinogenesis. 2013 Nov; 34(11):2543-7. PMID: 23946494; PMCID: PMC3810842.
      Citations: 7     Fields:    Translation:HumansCells
    34. Xu E, Gong Y, Gu J, Jie L, Ajani JA, Wu X. Risk assessment of esophageal adenocarcinoma using ?-H2AX assay. Cancer Epidemiol Biomarkers Prev. 2013 Oct; 22(10):1797-804. PMID: 23904462; PMCID: PMC3824382.
      Citations: 7     Fields:    Translation:HumansCells
    35. Gu J, Wu X. Re: short telomere length, cancer survival, and cancer risk in 47 102 individuals. J Natl Cancer Inst. 2013 Aug 07; 105(15):1157. PMID: 23868923.
      Citations: 9     Fields:    Translation:HumansCells
    36. Reyes-Gibby CC, Swartz MD, Yu X, Wu X, Yennurajalingam S, Anderson KO, Spitz MR, Shete S. Symptom clusters of pain, depressed mood, and fatigue in lung cancer: assessing the role of cytokine genes. Support Care Cancer. 2013 Nov; 21(11):3117-25. PMID: 23852407; PMCID: PMC3923575.
      Citations: 21     Fields:    Translation:Humans
    37. Xu E, Sun W, Gu J, Chow WH, Ajani JA, Wu X. Association of mitochondrial DNA copy number in peripheral blood leukocytes with risk of esophageal adenocarcinoma. Carcinogenesis. 2013 Nov; 34(11):2521-4. PMID: 23803692; PMCID: PMC3810839.
      Citations: 19     Fields:    Translation:HumansCells
    38. Wang Y, Gu J, Roth JA, Hildebrandt MA, Lippman SM, Ye Y, Minna JD, Wu X. Pathway-based serum microRNA profiling and survival in patients with advanced stage non-small cell lung cancer. Cancer Res. 2013 Aug 01; 73(15):4801-9. PMID: 23774211; PMCID: PMC3760306.
      Citations: 47     Fields:    Translation:Humans
    39. Wu X, Wang L, Ye Y, Aakre JA, Pu X, Chang GC, Yang PC, Roth JA, Marks RS, Lippman SM, Chang JY, Lu C, Deschamps C, Su WC, Wang WC, Huang MS, Chang DW, Li Y, Pankratz VS, Minna JD, Hong WK, Hildebrandt MA, Hsiung CA, Yang P. Genome-wide association study of genetic predictors of overall survival for non-small cell lung cancer in never smokers. Cancer Res. 2013 Jul 01; 73(13):4028-38. PMID: 23704207; PMCID: PMC3719971.
      Citations: 27     Fields:    Translation:Humans
    40. Chung CC, Kanetsky PA, Wang Z, Hildebrandt MA, Koster R, Skotheim RI, Kratz CP, Turnbull C, Cortessis VK, Bakken AC, Bishop DT, Cook MB, Erickson RL, Jacobs KB, Korde LA, Kraggerud SM, Lothe RA, Loud JT, Rahman N, Skinner EC, Thomas DC, Wu X, Yeager M, Schumacher FR, Greene MH, Schwartz SM, McGlynn KA, Chanock SJ, Nathanson KL, Foss? SD. Meta-analysis identifies four new loci associated with testicular germ cell tumor. Nat Genet. 2013 Jun; 45(6):680-5. PMID: 23666239; PMCID: PMC3723930.
      Citations: 87     Fields:    Translation:HumansCells
    41. Wang J, Wu X, Kamat A, Barton Grossman H, Dinney CP, Lin J. Fluid intake, genetic variants of UDP-glucuronosyltransferases, and bladder cancer risk. Br J Cancer. 2013 Jun 11; 108(11):2372-80. PMID: 23632476; PMCID: PMC3681021.
      Citations: 13     Fields:    Translation:Humans
    42. Sacerdote C, Guarrera S, Ricceri F, Pardini B, Polidoro S, Allione A, Critelli R, Russo A, Andrew AS, Ye Y, Wu X, Kiemeney LA, Bosio A, Casetta G, Cucchiarale G, Destefanis P, Gontero P, Rolle L, Zitella A, Fontana D, Vineis P, Matullo G. Polymorphisms in the XRCC1 gene modify survival of bladder cancer patients treated with chemotherapy. Int J Cancer. 2013 Oct 15; 133(8):2004-9. PMID: 23553206; PMCID: PMC3804126.
      Citations: 17     Fields:    Translation:HumansCells
    43. Pickering CR, Zhang J, Yoo SY, Bengtsson L, Moorthy S, Neskey DM, Zhao M, Ortega Alves MV, Chang K, Drummond J, Cortez E, Xie TX, Zhang D, Chung W, Issa JP, Zweidler-McKay PA, Wu X, El-Naggar AK, Weinstein JN, Wang J, Muzny DM, Gibbs RA, Wheeler DA, Myers JN, Frederick MJ. Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers. Cancer Discov. 2013 Jul; 3(7):770-81. PMID: 23619168; PMCID: PMC3858325.
      Citations: 241     Fields:    Translation:HumansCells
    44. Monda KL, Chen GK, Taylor KC, Palmer C, Edwards TL, Lange LA, Ng MC, Adeyemo AA, Allison MA, Bielak LF, Chen G, Graff M, Irvin MR, Rhie SK, Li G, Liu Y, Liu Y, Lu Y, Nalls MA, Sun YV, Wojczynski MK, Yanek LR, Aldrich MC, Ademola A, Amos CI, Bandera EV, Bock CH, Britton A, Broeckel U, Cai Q, Caporaso NE, Carlson CS, Carpten J, Casey G, Chen WM, Chen F, Chen YD, Chiang CW, Coetzee GA, Demerath E, Deming-Halverson SL, Driver RW, Dubbert P, Feitosa MF, Feng Y, Freedman BI, Gillanders EM, Gottesman O, Guo X, Haritunians T, Harris T, Harris CC, Hennis AJ, Hernandez DG, McNeill LH, Howard TD, Howard BV, Howard VJ, Johnson KC, Kang SJ, Keating BJ, Kolb S, Kuller LH, Kutlar A, Langefeld CD, Lettre G, Lohman K, Lotay V, Lyon H, Manson JE, Maixner W, Meng YA, Monroe KR, Morhason-Bello I, Murphy AB, Mychaleckyj JC, Nadukuru R, Nathanson KL, Nayak U, N'diaye A, Nemesure B, Wu SY, Leske MC, Neslund-Dudas C, Neuhouser M, Nyante S, Ochs-Balcom H, Ogunniyi A, Ogundiran TO, Ojengbede O, Olopade OI, Palmer JR, Ruiz-Narvaez EA, Palmer ND, Press MF, Rampersaud E, Rasmussen-Torvik LJ, Rodriguez-Gil JL, Salako B, Schadt EE, Schwartz AG, Shriner DA, Siscovick D, Smith SB, Wassertheil-Smoller S, Speliotes EK, Spitz MR, Sucheston L, Taylor H, Tayo BO, Tucker MA, Van Den Berg DJ, Edwards DR, Wang Z, Wiencke JK, Winkler TW, Witte JS, Wrensch M, Wu X, Yang JJ, Levin AM, Young TR, Zakai NA, Cushman M, Zanetti KA, Zhao JH, Zhao W, Zheng Y, Zhou J, Ziegler RG, Zmuda JM, Fernandes JK, Gilkeson GS, Kamen DL, Hunt KJ, Spruill IJ, Ambrosone CB, Ambs S, Arnett DK, Atwood L, Becker DM, Berndt SI, Bernstein L, Blot WJ, Borecki IB, Bottinger EP, Bowden DW, Burke G, Chanock SJ, Cooper RS, Ding J, Duggan D, Evans MK, Fox C, Garvey WT, Bradfield JP, Hakonarson H, Grant SF, Hsing A, Chu L, Hu JJ, Huo D, Ingles SA, John EM, Jordan JM, Kabagambe EK, Kardia SL, Kittles RA, Goodman PJ, Klein EA, Kolonel LN, Le Marchand L, Liu S, McKnight B, Millikan RC, Mosley TH, Padhukasahasram B, Williams LK, Patel SR, Peters U, Pettaway CA, Peyser PA, Psaty BM, Redline S, Rotimi CN, Rybicki BA, Schreiner PJ, Signorello LB, Singleton AB, Stanford JL, Strom SS, Thun MJ, Vitolins M, Zheng W, Moore JH, Williams SM, Ketkar S, Zhu X, Zonderman AB, NABEC Consortium, UKBEC Consortium, BioBank Japan Project, AGEN Consortium, Kooperberg C, Papanicolaou GJ, Henderson BE, Reiner AP, Hirschhorn JN, Loos RJ, North KE, Haiman CA, Sale MM. A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nat Genet. 2013 Jun; 45(6):690-6. PMID: 23583978; PMCID: PMC3694490.
      Citations: 140     Fields:    Translation:Humans
    45. Spitz MR, Amos CI, Land S, Wu X, Dong Q, Wenzlaff AS, Schwartz AG. Role of selected genetic variants in lung cancer risk in African Americans. J Thorac Oncol. 2013 Apr; 8(4):391-7. PMID: 23454887; PMCID: PMC3623962.
      Citations: 15     Fields:    Translation:Humans
    46. Lee EK, Ye Y, Kamat AM, Wu X. Genetic variations in regulator of G-protein signaling (RGS) confer risk of bladder cancer. Cancer. 2013 May 01; 119(9):1643-51. PMID: 23529717; PMCID: PMC4004376.
      Citations: 8     Fields:    Translation:Humans
    47. Seurin D, Lombet A, Babajko S, Ricort JM, Godeau F. Insulin-like growth factor binding proteins increase intracellular calcium levels in two different cell lines. PLoS One. 2013; 8(3):e59323. PMID: 23527161; PMCID: PMC3602172.
      Citations: 6     Fields:    Translation:HumansCells
    48. Schumacher FR, Wang Z, Skotheim RI, Koster R, Chung CC, Hildebrandt MA, Kratz CP, Bakken AC, Bishop DT, Cook MB, Erickson RL, Greene MH, Jacobs KB, Kanetsky PA, Kolonel LN, Loud JT, Korde LA, Le Marchand L, Lewinger JP, Lothe RA, Pike MC, Rahman N, Rubertone MV, Schwartz SM, Siegmund KD, Skinner EC, Turnbull C, Van Den Berg DJ, Wu X, Yeager M, Nathanson KL, Chanock SJ, Cortessis VK, McGlynn KA, Foss? SD. Testicular germ cell tumor susceptibility associated with the UCK2 locus on chromosome 1q23. Hum Mol Genet. 2013 Jul 01; 22(13):2748-53. PMID: 23462292; PMCID: PMC3674801.
      Citations: 40     Fields:    Translation:HumansCells
    49. Zhang X, Huang M, Wu X, Kadlubar S, Lin J, Yu X, Fan C, Ning B, Kadlubar FF. GSTM1 copy number and promoter haplotype as predictors for risk of recurrence and/or second primary tumor in patients with head and neck cancer. Pharmgenomics Pers Med. 2013; 6:9-17. PMID: 23526580; PMCID: PMC3596140.
      Citations: 2     
    50. Wu X, Ajani JA, Gu J, Chang DW, Tan W, Hildebrandt MA, Huang M, Wang KK, Hawk E. MicroRNA expression signatures during malignant progression from Barrett's esophagus to esophageal adenocarcinoma. Cancer Prev Res (Phila). 2013 Mar; 6(3):196-205. PMID: 23466817; PMCID: PMC3608471.
      Citations: 53     Fields:    Translation:HumansCells
    51. Xie H, Wu X, Wang S, Chang D, Pollock RE, Lev D, Gu J. Long telomeres in peripheral blood leukocytes are associated with an increased risk of soft tissue sarcoma. Cancer. 2013 May 15; 119(10):1885-91. PMID: 23408253; PMCID: PMC3807211.
      Citations: 20     Fields:    Translation:HumansCells
    52. Shu X, Lin J, Wood CG, Tannir NM, Wu X. Energy balance, polymorphisms in the mTOR pathway, and renal cell carcinoma risk. J Natl Cancer Inst. 2013 Mar 20; 105(6):424-32. PMID: 23378641; PMCID: PMC3601952.
      Citations: 12     Fields:    Translation:HumansCells
    53. Pu X, Roth JA, Hildebrandt MA, Ye Y, Wei H, Minna JD, Lippman SM, Wu X. MicroRNA-related genetic variants associated with clinical outcomes in early-stage non-small cell lung cancer patients. Cancer Res. 2013 Mar 15; 73(6):1867-75. PMID: 23378343; PMCID: PMC3602350.
      Citations: 17     Fields:    Translation:Humans
    54. Xie H, Lev D, Gong Y, Wang S, Pollock RE, Wu X, Gu J. Reduced mitochondrial DNA copy number in peripheral blood leukocytes increases the risk of soft tissue sarcoma. Carcinogenesis. 2013 May; 34(5):1039-43. PMID: 23349016.
      Citations: 17     Fields:    Translation:HumansCells
    55. Swartz MD, Peterson CB, Lupo PJ, Wu X, Forman MR, Spitz MR, Hernandez LM, Vannucci M, Shete S. Investigating multiple candidate genes and nutrients in the folate metabolism pathway to detect genetic and nutritional risk factors for lung cancer. PLoS One. 2013; 8(1):e53475. PMID: 23372658; PMCID: PMC3553105.
      Citations: 23     Fields:    Translation:Humans
    56. Ke HL, Chen M, Ye Y, Hildebrandt MA, Wu WJ, Wei H, Huang M, Chang DW, Dinney CP, Wu X. Genetic variations in micro-RNA biogenesis genes and clinical outcomes in non-muscle-invasive bladder cancer. Carcinogenesis. 2013 May; 34(5):1006-11. PMID: 23322153; PMCID: PMC3643413.
      Citations: 14     Fields:    Translation:Humans
    57. Wen CP, Tsai MK, Wai JP, Wu X. Promoting increased physical activity and reduced inactivity - Authors' reply. Lancet. 2013 Jan 12; 381(9861):114-5. PMID: 23312751.
      Citations: 1     Fields:    Translation:Humans
    58. He Y, Gong Y, Lin J, Chang DW, Gu J, Roth JA, Wu X. Ionizing radiation-induced ?-H2AX activity in whole blood culture and the risk of lung cancer. Cancer Epidemiol Biomarkers Prev. 2013 Mar; 22(3):443-51. PMID: 23300022; PMCID: PMC3601549.
      Citations: 3     Fields:    Translation:HumansCells
    59. Gu J, Wang Y, Wu X. MicroRNA in the pathogenesis and prognosis of esophageal cancer. Curr Pharm Des. 2013; 19(7):1292-300. PMID: 23092349.
      Citations: 56     Fields:    Translation:Humans
    60. Shen H, Fridley BL, Song H, Lawrenson K, Cunningham JM, Ramus SJ, Cicek MS, Tyrer J, Stram D, Larson MC, PRACTICAL Consortium, Ziogas A, Zheng W, Yang HP, Wu AH, Wozniak EL, Woo YL, Winterhoff B, Wik E, Whittemore AS, Wentzensen N, Weber RP, Vitonis AF, Vincent D, Vierkant RA, Vergote I, Van Den Berg D, Van Altena AM, Tworoger SS, Thompson PJ, Tessier DC, Terry KL, Teo SH, Templeman C, Stram DO, Southey MC, Sieh W, Siddiqui N, Shvetsov YB, Shu XO, Shridhar V, Wang-Gohrke S, Severi G, Schwaab I, Salvesen HB, Rzepecka IK, Runnebaum IB, Rossing MA, Rodriguez-Rodriguez L, Risch HA, Renner SP, Poole EM, Pike MC, Phelan CM, Pelttari LM, Pejovic T, Paul J, Orlow I, Omar SZ, Olson SH, Odunsi K, Nickels S, Nevanlinna H, Ness RB, Narod SA, Nakanishi T, Moysich KB, Monteiro AN, Moes-Sosnowska J, Modugno F, Menon U, McLaughlin JR, McGuire V, Matsuo K, Adenan NA, Massuger LF, Lurie G, Lundvall L, Lubinski J, Lissowska J, Levine DA, Leminen A, Lee AW, Le ND, Lambrechts S, Lambrechts D, Kupryjanczyk J, Krakstad C, Konecny GE, Kiemeney LA, Kelemen LE, Keeney GL, Karlan BY, Karevan R, Kalli KR, Kajiyama H, Ji BT, Jensen A, Jakubowska A, Iversen E, Hosono S, Hoatlin M, Hillemanns P, Heitz F, Hein R, Harter P, Halle MK, Hall P, Gronwald J, Gore M, Goodman MT, Giles GG, Gentry-Maharaj A, Garcia-Closas M, Flanagan JM, Fasching PA, Ekici AB, Edwards R, Eccles D, Easton DF, du Bois A, Doherty JA, Despierre E, Dansonka-Mieszkowska A, Cybulski C, Cramer DW, Cook LS, Chen X, Charbonneau B, Chang-Claude J, Campbell I, Butzow R, Bunker CH, Brueggmann D, Brown R, Brooks-Wilson A, Brinton LA, Bogdanova N, Block MS, Benjamin E, Beesley J, Beckmann MW, Bandera EV, Baglietto L, Armasu SM, Antonenkova N, Anton-Culver H, Aben KK, Liang D, Wu X, Lu K, Hildebrandt MA, Australian Ovarian Cancer Study Group, Australian Cancer Study, Schildkraut JM, Sellers TA, Huntsman D, Berchuck A, Chenevix-Trench G, Gayther SA, Pharoah PD, Laird PW, Goode EL, Pearce CL, K?bel M, Kjaer SK, H?gdall CK, H?gdall E, D?rst M, D?rk T, Bacot F. Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nat Commun. 2013; 4:1628. PMID: 23535649; PMCID: PMC3848248.
      Citations: 92     Fields:    Translation:HumansCells
    61. Wilkinson AV, Gabriel KP, Wang J, Bondy ML, Dong Q, Wu X, Shete S, Spitz MR. Sensation-seeking genes and physical activity in youth. Genes Brain Behav. 2013 Mar; 12(2):181-8. PMID: 23190435; PMCID: PMC3581711.
      Citations: 14     Fields:    Translation:Humans
    62. Andrew AS, Hu T, Gu J, Gui J, Ye Y, Marsit CJ, Kelsey KT, Schned AR, Tanyos SA, Pendleton EM, Mason RA, Morlock EV, Zens MS, Li Z, Moore JH, Wu X, Karagas MR. HSD3B and gene-gene interactions in a pathway-based analysis of genetic susceptibility to bladder cancer. PLoS One. 2012; 7(12):e51301. PMID: 23284679; PMCID: PMC3526593.
      Citations: 8     Fields:    Translation:HumansCells
    63. Wei H, Kamat AM, Aldousari S, Ye Y, Huang M, Dinney CP, Wu X. Genetic variations in the transforming growth factor beta pathway as predictors of bladder cancer risk. PLoS One. 2012; 7(12):e51758. PMID: 23251617; PMCID: PMC3520916.
      Citations: 12     Fields:    Translation:HumansCells
    64. Walsh KM, Gorlov IP, Hansen HM, Wu X, Spitz MR, Zhang H, Lu EY, Wenzlaff AS, Sison JD, Wei C, Lloyd SM, Chen W, Frazier ML, Seldin MF, Bierut LJ, Bracci PM, Wrensch MR, Schwartz AG, Wiencke JK, Amos CI. Fine-mapping of the 5p15.33, 6p22.1-p21.31, and 15q25.1 regions identifies functional and histology-specific lung cancer susceptibility loci in African-Americans. Cancer Epidemiol Biomarkers Prev. 2013 Feb; 22(2):251-60. PMID: 23221128; PMCID: PMC3565099.
      Citations: 12     Fields:    Translation:HumansCells
    65. Henrion M, Frampton M, Scelo G, Purdue M, Ye Y, Broderick P, Ritchie A, Kaplan R, Meade A, McKay J, Johansson M, Lathrop M, Larkin J, Rothman N, Wang Z, Chow WH, Stevens VL, Ryan Diver W, Gapstur SM, Albanes D, Virtamo J, Wu X, Brennan P, Chanock S, Eisen T, Houlston RS. Common variation at 2q22.3 (ZEB2) influences the risk of renal cancer. Hum Mol Genet. 2013 Feb 15; 22(4):825-31. PMID: 23184150; PMCID: PMC3554205.
      Citations: 31     Fields:    Translation:HumansCells
    66. Reyes-Gibby CC, Wang J, Spitz M, Wu X, Yennurajalingam S, Shete S. Genetic variations in interleukin-8 and interleukin-10 are associated with pain, depressed mood, and fatigue in lung cancer patients. J Pain Symptom Manage. 2013 Aug; 46(2):161-72. PMID: 23149083; PMCID: PMC3578112.
      Citations: 29     Fields:    Translation:Humans
    67. Peters GJ, Ruiter R, Kok G. Address physical inactivity, but avoid stressing harms. Lancet. 2012 Nov 03; 380(9853):1554; author reply 1554-5. PMID: 23122242.
      Citations:    Fields:    Translation:Humans
    68. Walsh KM, Amos CI, Wenzlaff AS, Gorlov IP, Sison JD, Wu X, Spitz MR, Hansen HM, Lu EY, Wei C, Zhang H, Chen W, Lloyd SM, Frazier ML, Bracci PM, Seldin MF, Wrensch MR, Schwartz AG, Wiencke JK. Association study of nicotinic acetylcholine receptor genes identifies a novel lung cancer susceptibility locus near CHRNA1 in African-Americans. Oncotarget. 2012 Nov; 3(11):1428-38. PMID: 23232035; PMCID: PMC3717803.
      Citations: 6     Fields:    Translation:Humans
    69. Wen CP, Lin J, Yang YC, Tsai MK, Tsao CK, Etzel C, Huang M, Hsu CY, Ye Y, Mishra L, Hawk E, Wu X. Hepatocellular carcinoma risk prediction model for the general population: the predictive power of transaminases. J Natl Cancer Inst. 2012 Oct 17; 104(20):1599-611. PMID: 23073549; PMCID: PMC3692381.
      Citations: 44     Fields:    Translation:Humans
    70. Wang J, Spitz MR, Amos CI, Wu X, Wetter DW, Cinciripini PM, Shete S. Method for evaluating multiple mediators: mediating effects of smoking and COPD on the association between the CHRNA5-A3 variant and lung cancer risk. PLoS One. 2012; 7(10):e47705. PMID: 23077662; PMCID: PMC3471886.
      Citations: 16     Fields:    Translation:Humans
    71. Ye Y, Madison B, Wu X, Rustgi AK. A LIN28B polymorphism predicts for colon cancer survival. Cancer Biol Ther. 2012 Dec; 13(14):1390-5. PMID: 23052130; PMCID: PMC3542229.
      Citations: 8     Fields:    Translation:Humans
    72. Pu X, Ye Y, Spitz MR, Wang L, Gu J, Lippman SM, Hildebrandt MA, Hong WK, Minna JD, Roth JA, Yang P, Wu X. Predictors of survival in never-smokers with non-small cell lung cancer: a large-scale, two-phase genetic study. Clin Cancer Res. 2012 Nov 01; 18(21):5983-91. PMID: 22977190; PMCID: PMC3640870.
      Citations: 7     Fields:    Translation:Humans
    73. Timofeeva MN, Hung RJ, Rafnar T, Christiani DC, Field JK, Risch A, McKay JD, Wang Y, Dai J, Gaborieau V, McLaughlin J, Brenner D, Narod SA, Caporaso NE, Albanes D, Thun M, Eisen T, Wichmann HE, Rosenberger A, Han Y, Chen W, Zhu D, Spitz M, Wu X, Pande M, Zhao Y, Zaridze D, Szeszenia-Dabrowska N, Lissowska J, Rudnai P, Fabianova E, Mates D, Bencko V, Foretova L, Janout V, Krokan HE, Gabrielsen ME, Skorpen F, Vatten L, Chen C, Goodman G, Lathrop M, Benhamou S, Nelis M, Metspalu A, Raji O, Chen Y, Gosney J, Liloglou T, Muley T, Dienemann H, Thorleifsson G, Shen H, Stefansson K, Brennan P, Amos CI, Houlston R, Landi MT, Transdisciplinary Research in Cancer of the Lung (TRICL) Research Team, Bickeb?ller H, Nj?lstad I, Vooder T, V?lk K. Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controls. Hum Mol Genet. 2012 Nov 15; 21(22):4980-95. PMID: 22899653; PMCID: PMC3607485.
      Citations: 118     Fields:    Translation:Humans
    74. Hartz SM, Short SE, Saccone NL, Culverhouse R, Chen L, Schwantes-An TH, Coon H, Han Y, Stephens SH, Sun J, Chen X, Ducci F, Dueker N, Franceschini N, Frank J, Geller F, Gubjartsson D, Hansel NN, Jiang C, Keskitalo-Vuokko K, Liu Z, Michel M, Rawal R, Rosenberger A, Scheet P, Shaffer JR, Teumer A, Thompson JR, Vink JM, Vogelzangs N, Wenzlaff AS, Wheeler W, Xiao X, Yang BZ, Aggen SH, Balmforth AJ, Baumeister SE, Beaty T, Bennett S, Bergen AW, Boyd HA, Broms U, Campbell H, Chatterjee N, Chen J, Cheng YC, Cichon S, Couper D, Cucca F, Dick DM, Foroud T, Furberg H, Giegling I, Gu F, Hall AS, Han S, Hartmann AM, Hayward C, Hewitt JK, Hottenga JJ, Jensen MK, Jousilahti P, Kaakinen M, Kittner SJ, Konte B, Korhonen T, Landi MT, Laatikainen T, Leppert M, Levy SM, Mathias RA, McNeil DW, Medland SE, Montgomery GW, Muley T, Murray T, Nauck M, North K, Pergadia M, Polasek O, Ramos EM, Ripatti S, Risch A, Ruczinski I, Rudan I, Salomaa V, Schlessinger D, Terracciano A, Uda M, Willemsen G, Wu X, Abecasis G, Barnes K, Boerwinkle E, Boomsma DI, Caporaso N, Duan J, Edenberg HJ, Francks C, Gejman PV, Gelernter J, Hops H, Jarvelin MR, Viikari J, Kendler KS, Levinson DF, Marazita ML, Marchini J, Melbye M, Mitchell BD, Murray JC, Penninx BW, Raitakari O, Rietschel M, Rujescu D, Samani NJ, Sanders AR, Schwartz AG, Shete S, Shi J, Spitz M, Stefansson K, Swan GE, Thorgeirsson T, Wei Q, Wichmann HE, Amos CI, Breslau N, Cannon DS, Ehringer M, Grucza R, Hatsukami D, Heath A, Johnson EO, Kaprio J, Madden P, Martin NG, Stevens VL, Stitzel JA, Weiss RB, Kraft P, Bierut LJ, Lyytik?inen LP, H?llfors J, Heikkil? K, Styrk?rsd?ttir U, Bickeb?ller H, Grabe HJ, K?h?nen M, Lehtim?ki T, N?then MM, V?lzke H. Increased genetic vulnerability to smoking at CHRNA5 in early-onset smokers. Arch Gen Psychiatry. 2012 Aug; 69(8):854-60. PMID: 22868939; PMCID: PMC3482121.
      Citations: 43     Fields:    Translation:Humans
    75. Wen CP, Wu X. Stressing harms of physical inactivity to promote exercise. Lancet. 2012 Jul 21; 380(9838):192-3. PMID: 22818933.
      Citations: 35     Fields:    Translation:Humans
    76. Kim JY, Hildebrandt MA, Pu X, Ye Y, Correa AM, Vaporciyan AA, Wu X, Roth JA. Variations in the vascular endothelial growth factor pathway predict pulmonary complications. Ann Thorac Surg. 2012 Oct; 94(4):1079-84; discussion 1084-5. PMID: 22795057; PMCID: PMC3466075.
      Citations: 6     Fields:    Translation:Humans
    77. Chang DW, Gu J, Wu X. Germline prognostic markers for urinary bladder cancer: obstacles and opportunities. Urol Oncol. 2012 Jul-Aug; 30(4):524-32. PMID: 22742565; PMCID: PMC3824379.
      Citations: 9     Fields:    Translation:Humans
    78. Majumdar A, Curley SA, Wu X, Brown P, Hwang JP, Shetty K, Yao ZX, He AR, Li S, Katz L, Farci P, Mishra L. Hepatic stem cells and transforming growth factor ? in hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2012 Sep; 9(9):530-8. PMID: 22710573; PMCID: PMC3745216.
      Citations: 68     Fields:    Translation:HumansAnimalsCells
    79. Wei H, Kamat A, Chen M, Ke HL, Chang DW, Yin J, Grossman HB, Dinney CP, Wu X. Association of polymorphisms in oxidative stress genes with clinical outcomes for bladder cancer treated with Bacillus Calmette-Gu?rin. PLoS One. 2012; 7(6):e38533. PMID: 22701660; PMCID: PMC3373532.
      Citations: 14     Fields:    Translation:Humans
    80. Lin M, Eng C, Hawk ET, Huang M, Lin J, Gu J, Ellis LM, Wu X. Identification of polymorphisms in ultraconserved elements associated with clinical outcomes in locally advanced colorectal adenocarcinoma. Cancer. 2012 Dec 15; 118(24):6188-98. PMID: 22673945; PMCID: PMC3465518.
      Citations: 9     Fields:    Translation:HumansAnimalsCells
    81. Lin J, Lu C, Stewart DJ, Gu J, Huang M, Chang DW, Lippman SM, Wu X. Systematic evaluation of apoptotic pathway gene polymorphisms and lung cancer risk. Carcinogenesis. 2012 Sep; 33(9):1699-706. PMID: 22665367; PMCID: PMC3514904.
      Citations: 11     Fields:    Translation:HumansCells
    82. Lin M, Gu J, Eng C, Ellis LM, Hildebrandt MA, Lin J, Huang M, Calin GA, Wang D, Dubois RN, Hawk ET, Wu X. Genetic polymorphisms in MicroRNA-related genes as predictors of clinical outcomes in colorectal adenocarcinoma patients. Clin Cancer Res. 2012 Jul 15; 18(14):3982-91. PMID: 22661538; PMCID: PMC4141857.
      Citations: 35     Fields:    Translation:Humans
    83. Pilarski R, Patel DA, Weitzel J, McVeigh T, Dorairaj JJ, Heneghan HM, Miller N, Weidhaas JB, Kerin MJ, McKenna M, Wu X, Hildebrandt M, Zelterman D, Sand S, Shulman LP. The KRAS-variant is associated with risk of developing double primary breast and ovarian cancer. PLoS One. 2012; 7(5):e37891. PMID: 22662244; PMCID: PMC3360659.
      Citations: 19     Fields:    Translation:Humans
    84. Hildebrandt MA, Lippman SM, Etzel CJ, Kim E, Lee JJ, Khuri FR, Spitz MR, Lotan R, Hong WK, Wu X. Genetic variants in the PI3K/PTEN/AKT/mTOR pathway predict head and neck cancer patient second primary tumor/recurrence risk and response to retinoid chemoprevention. Clin Cancer Res. 2012 Jul 01; 18(13):3705-13. PMID: 22577058; PMCID: PMC3404728.
      Citations: 16     Fields:    Translation:HumansCells
    85. Spitz MR, Gorlov IP, Dong Q, Wu X, Chen W, Chang DW, Etzel CJ, Caporaso NE, Zhao Y, Christiani DC, Brennan P, Albanes D, Shi J, Thun M, Landi MT, Amos CI. Multistage analysis of variants in the inflammation pathway and lung cancer risk in smokers. Cancer Epidemiol Biomarkers Prev. 2012 Jul; 21(7):1213-21. PMID: 22573796; PMCID: PMC3487592.
      Citations: 19     Fields:    Translation:Humans
    86. Jacobs KB, Yeager M, Zhou W, Wacholder S, Wang Z, Rodriguez-Santiago B, Hutchinson A, Deng X, Liu C, Horner MJ, Cullen M, Epstein CG, Burdett L, Dean MC, Chatterjee N, Sampson J, Chung CC, Kovaks J, Gapstur SM, Stevens VL, Teras LT, Gaudet MM, Albanes D, Weinstein SJ, Virtamo J, Taylor PR, Freedman ND, Abnet CC, Goldstein AM, Hu N, Yu K, Yuan JM, Liao L, Ding T, Qiao YL, Gao YT, Koh WP, Xiang YB, Tang ZZ, Fan JH, Aldrich MC, Amos C, Blot WJ, Bock CH, Gillanders EM, Harris CC, Haiman CA, Henderson BE, Kolonel LN, Le Marchand L, McNeill LH, Rybicki BA, Schwartz AG, Signorello LB, Spitz MR, Wiencke JK, Wrensch M, Wu X, Zanetti KA, Ziegler RG, Figueroa JD, Garcia-Closas M, Malats N, Marenne G, Prokunina-Olsson L, Baris D, Schwenn M, Johnson A, Landi MT, Goldin L, Consonni D, Bertazzi PA, Rotunno M, Rajaraman P, Andersson U, Beane Freeman LE, Berg CD, Buring JE, Butler MA, Carreon T, Feychting M, Ahlbom A, Gaziano JM, Giles GG, Hallmans G, Hankinson SE, Hartge P, Henriksson R, Inskip PD, Johansen C, Landgren A, McKean-Cowdin R, Michaud DS, Melin BS, Peters U, Ruder AM, Sesso HD, Severi G, Shu XO, Visvanathan K, White E, Wolk A, Zeleniuch-Jacquotte A, Zheng W, Silverman DT, Kogevinas M, Gonzalez JR, Villa O, Li D, Duell EJ, Risch HA, Olson SH, Kooperberg C, Wolpin BM, Jiao L, Hassan M, Wheeler W, Arslan AA, Bueno-de-Mesquita HB, Fuchs CS, Gallinger S, Gross MD, Holly EA, Klein AP, LaCroix A, Mandelson MT, Petersen G, Boutron-Ruault MC, Bracci PM, Canzian F, Chang K, Cotterchio M, Giovannucci EL, Goggins M, Hoffman Bolton JA, Jenab M, Khaw KT, Krogh V, Kurtz RC, McWilliams RR, Mendelsohn JB, Rabe KG, Riboli E, Tobias GS, Trichopoulos D, Elena JW, Yu H, Amundadottir L, Stolzenberg-Solomon RZ, Kraft P, Schumacher F, Stram D, Savage SA, Mirabello L, Andrulis IL, Wunder JS, Barkauskas DA, Gorlick RG, Purdue M, Chow WH, Moore LE, Schwartz KL, Davis FG, Hsing AW, Berndt SI, Black A, Wentzensen N, Brinton LA, Lissowska J, Peplonska B, McGlynn KA, Cook MB, Graubard BI, Kratz CP, Greene MH, Erickson RL, Hunter DJ, Thomas G, Hoover RN, Real FX, Fraumeni JF, Caporaso NE, Tucker M, Rothman N, Chanock SJ, Tj?nneland A, Pati?o Garc?a A, Sierrases?maga L, P?rez-Jurado LA. Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet. 2012 May 06; 44(6):651-8. PMID: 22561519; PMCID: PMC3372921.
      Citations: 275     Fields:    Translation:Humans
    87. Dai J, Gu J, Huang M, Eng C, Kopetz ES, Ellis LM, Hawk E, Wu X. GWAS-identified colorectal cancer susceptibility loci associated with clinical outcomes. Carcinogenesis. 2012 Jul; 33(7):1327-31. PMID: 22505654; PMCID: PMC4072910.
      Citations: 30     Fields:    Translation:Humans
    88. Fu YP, Kohaar I, Rothman N, Earl J, Figueroa JD, Ye Y, Tang W, Liu L, Garcia-Closas M, Muchmore B, Chatterjee N, Tarway M, Kogevinas M, Porter-Gill P, Baris D, Mumy A, Albanes D, Purdue MP, Hutchinson A, Carrato A, Serra C, Lloreta J, Johnson A, Schwenn M, Karagas MR, Schned A, Diver WR, Gapstur SM, Thun MJ, Virtamo J, Chanock SJ, Fraumeni JF, Silverman DT, Wu X, Real FX, Prokunina-Olsson L, Malats N, Tard?n A, Garc?a-Closas R. Common genetic variants in the PSCA gene influence gene expression and bladder cancer risk. Proc Natl Acad Sci U S A. 2012 Mar 27; 109(13):4974-9. PMID: 22416122; PMCID: PMC3324016.
      Citations: 47     Fields:    Translation:HumansCells
    89. Lin J, Forman MR, Wang J, Grossman HB, Chen M, Dinney CP, Hawk ET, Wu X. Intake of red meat and heterocyclic amines, metabolic pathway genes and bladder cancer risk. Int J Cancer. 2012 Oct 15; 131(8):1892-903. PMID: 22261697; PMCID: PMC3415602.
      Citations: 9     Fields:    Translation:Humans
    90. Chang J, Dinney CP, Huang M, Wu X, Gu J. Genetic variants in telomere-maintenance genes and bladder cancer risk. PLoS One. 2012; 7(2):e30665. PMID: 22363464; PMCID: PMC3281862.
      Citations: 11     Fields:    Translation:Humans
    91. Lin M, Eng C, Hawk ET, Huang M, Greisinger AJ, Gu J, Ellis LM, Wu X, Lin J. Genetic variants within ultraconserved elements and susceptibility to right- and left-sided colorectal adenocarcinoma. Carcinogenesis. 2012 Apr; 33(4):841-7. PMID: 22318908; PMCID: PMC3324446.
      Citations: 3     Fields:    Translation:HumansCells
    92. VanderWeele TJ, Asomaning K, Tchetgen Tchetgen EJ, Han Y, Spitz MR, Shete S, Wu X, Gaborieau V, Wang Y, McLaughlin J, Hung RJ, Brennan P, Amos CI, Christiani DC, Lin X. Genetic variants on 15q25.1, smoking, and lung cancer: an assessment of mediation and interaction. Am J Epidemiol. 2012 May 15; 175(10):1013-20. PMID: 22306564; PMCID: PMC3353137.
      Citations: 83     Fields:    Translation:HumansCells
    93. Hildebrandt MA, Tan W, Tamboli P, Huang M, Ye Y, Lin J, Lee JS, Wood CG, Wu X. Kinome expression profiling identifies IKBKE as a predictor of overall survival in clear cell renal cell carcinoma patients. Carcinogenesis. 2012 Apr; 33(4):799-803. PMID: 22266464; PMCID: PMC3324439.
      Citations: 13     Fields:    Translation:Humans
    94. Wagner KW, Ye Y, Lin J, Vaporciyan AA, Roth JA, Wu X. Genetic variations in epigenetic genes are predictors of recurrence in stage I or II non-small cell lung cancer patients. Clin Cancer Res. 2012 Jan 15; 18(2):585-92. PMID: 22252258; PMCID: PMC3373176.
      Citations: 11     Fields:    Translation:Humans
    95. Kamat AM, Dickstein RJ, Messetti F, Anderson R, Pretzsch SM, Gonzalez GN, Katz RL, Khanna A, Zaidi T, Wu X, Grossman HB, Dinney CP. Use of fluorescence in situ hybridization to predict response to bacillus Calmette-Gu?rin therapy for bladder cancer: results of a prospective trial. J Urol. 2012 Mar; 187(3):862-7. PMID: 22245325; PMCID: PMC3278506.
      Citations: 28     Fields:    Translation:HumansCTClinical Trials
    96. Ross W, Lynch P, Raju G, Rodriguez A, Burke T, Hafemeister L, Hawk E, Wu X, Dubois RN, Mishra L. Biomarkers, bundled payments, and colorectal cancer care. Genes Cancer. 2012 Jan; 3(1):16-22. PMID: 22893787; PMCID: PMC3415669.
      Citations: 4     
    97. Pan JY, Ajani JA, Gu J, Gong Y, Qin A, Quin A, Hung M, Wu X, Izzo JG. Association of Aurora-A (STK15) kinase polymorphisms with clinical outcome of esophageal cancer treated with preoperative chemoradiation. Cancer. 2012 Sep 01; 118(17):4346-53. PMID: 22213102; PMCID: PMC3831524.
      Citations: 14     Fields:    Translation:Humans
    98. Wilkinson AV, Bondy ML, Wu X, Wang J, Dong Q, D'Amelio AM, Prokhorov AV, Pu X, Yu RK, Etzel CJ, Shete S, Spitz MR. Cigarette experimentation in Mexican origin youth: psychosocial and genetic determinants. Cancer Epidemiol Biomarkers Prev. 2012 Jan; 21(1):228-38. PMID: 22028400; PMCID: PMC3382046.
      Citations: 9     Fields:    Translation:Humans
    99. Wei C, Han Y, Spitz MR, Wu X, Chancoco H, Akiva P, Rechavi G, Brand H, Wun I, Frazier ML, Amos CI. A case-control study of a sex-specific association between a 15q25 variant and lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2011 Dec; 20(12):2603-9. PMID: 22028403; PMCID: PMC3277830.
      Citations: 6     Fields:    Translation:HumansCells
    100. Wu X, Scelo G, Purdue MP, Rothman N, Johansson M, Ye Y, Wang Z, Zelenika D, Moore LE, Wood CG, Prokhortchouk E, Gaborieau V, Jacobs KB, Chow WH, Toro JR, Zaridze D, Lin J, Lubinski J, Trubicka J, Szeszenia-Dabrowska N, Lissowska J, Rudnai P, Fabianova E, Mates D, Jinga V, Bencko V, Slamova A, Holcatova I, Navratilova M, Janout V, Boffetta P, Colt JS, Davis FG, Schwartz KL, Banks RE, Selby PJ, Harnden P, Berg CD, Hsing AW, Grubb RL, Boeing H, Vineis P, Palli D, Tumino R, Krogh V, Panico S, Duell EJ, Navarro C, Ardanaz E, Dorronsoro M, Khaw KT, Allen NE, Bueno-de-Mesquita HB, Peeters PH, Trichopoulos D, Linseisen J, Overvad K, Romieu I, Riboli E, Stevens VL, Thun MJ, Diver WR, Gapstur SM, Pharoah PD, Easton DF, Albanes D, Virtamo J, Vatten L, Hveem K, Fletcher T, Koppova K, Cussenot O, Cancel-Tassin G, Benhamou S, Hildebrandt MA, Pu X, Foglio M, Lechner D, Hutchinson A, Yeager M, Fraumeni JF, Lathrop M, Skryabin KG, McKay JD, Gu J, Brennan P, Chanock SJ, Clavel-Chapelon F, Quir?s JR, Sanchez MJ, Ljungberg B, Tj?nneland A. A genome-wide association study identifies a novel susceptibility locus for renal cell carcinoma on 12p11.23. Hum Mol Genet. 2012 Jan 15; 21(2):456-62. PMID: 22010048; PMCID: PMC3276284.
      Citations: 53     Fields:    Translation:HumansCells
    101. Yin J, Lu K, Lin J, Wu L, Hildebrandt MA, Chang DW, Meyer L, Wu X, Liang D. Genetic variants in TGF-? pathway are associated with ovarian cancer risk. PLoS One. 2011; 6(9):e25559. PMID: 21984931; PMCID: PMC3184159.
      Citations: 19     Fields:    Translation:HumansCells
    102. Yin J, Lu C, Gu J, Lippman SM, Hildebrandt MA, Lin J, Stewart D, Spitz MR, Wu X. Common genetic variants in cell cycle pathway are associated with survival in stage III-IV non-small-cell lung cancer. Carcinogenesis. 2011 Dec; 32(12):1867-71. PMID: 21965272; PMCID: PMC3220611.
      Citations: 4     Fields:    Translation:Humans
    103. Tan W, Hildebrandt MA, Pu X, Huang M, Lin J, Matin SF, Tamboli P, Wood CG, Wu X. Role of inflammatory related gene expression in clear cell renal cell carcinoma development and clinical outcomes. J Urol. 2011 Nov; 186(5):2071-7. PMID: 21944129; PMCID: PMC3348612.
      Citations: 17     Fields:    Translation:HumansCells
    104. Spitz MR, Gorlov IP, Amos CI, Dong Q, Chen W, Etzel CJ, Gorlova OY, Chang DW, Pu X, Zhang D, Wang L, Cunningham JM, Yang P, Wu X. Variants in inflammation genes are implicated in risk of lung cancer in never smokers exposed to second-hand smoke. Cancer Discov. 2011 Oct; 1(5):420-9. PMID: 22586632; PMCID: PMC3919666.
      Citations: 19     Fields:    Translation:HumansPHPublic Health
    105. Wen CP, Wai JP, Tsai MK, Yang YC, Cheng TY, Lee MC, Chan HT, Tsao CK, Tsai SP, Wu X. Minimum amount of physical activity for reduced mortality and extended life expectancy: a prospective cohort study. Lancet. 2011 Oct 01; 378(9798):1244-53. PMID: 21846575.
      Citations: 518     Fields:    Translation:Humans
    106. Garcia-Closas M, Ye Y, Rothman N, Figueroa JD, Dinney CP, Chatterjee N, Prokunina-Olsson L, Wang Z, Lin J, Real FX, Jacobs KB, Baris D, Thun M, De Vivo I, Albanes D, Purdue MP, Kogevinas M, Kamat AM, Lerner SP, Grossman HB, Gu J, Pu X, Hutchinson A, Fu YP, Burdett L, Yeager M, Tang W, Serra C, Carrato A, Lloreta J, Johnson A, Schwenn M, Karagas MR, Schned A, Andriole G, Grubb R, Black A, Jacobs EJ, Diver WR, Gapstur SM, Weinstein SJ, Virtamo J, Hunter DJ, Caporaso N, Landi MT, Fraumeni JF, Silverman DT, Chanock SJ, Wu X, Malats N, Tard?n A, Garc?a-Closas R. A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3. Hum Mol Genet. 2011 Nov 01; 20(21):4282-9. PMID: 21824976; PMCID: PMC3188994.
      Citations: 51     Fields:    Translation:HumansCells
    107. Chen J, Wu X, Pande M, Amos CI, Killary AM, Sen S, Frazier ML. Susceptibility locus for lung cancer at 15q25.1 is not associated with risk of pancreatic cancer. Pancreas. 2011 Aug; 40(6):872-5. PMID: 21697764; PMCID: PMC3138891.
      Citations: 5     Fields:    Translation:HumansCells
    108. Hinch AG, Tandon A, Patterson N, Song Y, Rohland N, Palmer CD, Chen GK, Wang K, Buxbaum SG, Akylbekova EL, Aldrich MC, Ambrosone CB, Amos C, Bandera EV, Berndt SI, Bernstein L, Blot WJ, Bock CH, Boerwinkle E, Cai Q, Caporaso N, Casey G, Cupples LA, Deming SL, Diver WR, Divers J, Fornage M, Gillanders EM, Glessner J, Harris CC, Hu JJ, Ingles SA, Isaacs W, John EM, Kao WH, Keating B, Kittles RA, Kolonel LN, Larkin E, Le Marchand L, McNeill LH, Millikan RC, Murphy A, Musani S, Neslund-Dudas C, Nyante S, Papanicolaou GJ, Press MF, Psaty BM, Reiner AP, Rich SS, Rodriguez-Gil JL, Rotter JI, Rybicki BA, Schwartz AG, Signorello LB, Spitz M, Strom SS, Thun MJ, Tucker MA, Wang Z, Wiencke JK, Witte JS, Wrensch M, Wu X, Yamamura Y, Zanetti KA, Zheng W, Ziegler RG, Zhu X, Redline S, Hirschhorn JN, Henderson BE, Taylor HA, Price AL, Hakonarson H, Chanock SJ, Haiman CA, Wilson JG, Reich D, Myers SR. The landscape of recombination in African Americans. Nature. 2011 Jul 20; 476(7359):170-5. PMID: 21775986; PMCID: PMC3154982.
      Citations: 171     Fields:    Translation:HumansCells
    109. Pande M, Spitz MR, Wu X, Gorlov IP, Chen WV, Amos CI. Novel genetic variants in the chromosome 5p15.33 region associate with lung cancer risk. Carcinogenesis. 2011 Oct; 32(10):1493-9. PMID: 21771723; PMCID: PMC3179422.
      Citations: 41     Fields:    Translation:HumansCells
    110. Dai J, Gu J, Lu C, Lin J, Stewart D, Chang D, Roth JA, Wu X. Genetic variations in the regulator of G-protein signaling genes are associated with survival in late-stage non-small cell lung cancer. PLoS One. 2011; 6(6):e21120. PMID: 21698121; PMCID: PMC3117866.
      Citations: 15     Fields:    Translation:HumansCells
    111. Yoon HH, Catalano PJ, Murphy KM, Skaar TC, Philips S, Powell M, Montgomery EA, Hafez MJ, Offer SM, Liu G, Meltzer SJ, Wu X, Forastiere AA, Benson AB, Kleinberg LR, Gibson MK. Genetic variation in DNA-repair pathways and response to radiochemotherapy in esophageal adenocarcinoma: a retrospective cohort study of the Eastern Cooperative Oncology Group. BMC Cancer. 2011 May 17; 11:176. PMID: 21586140; PMCID: PMC3118194.
      Citations: 7     Fields:    Translation:HumansCells
    112. Lin M, Stewart DJ, Spitz MR, Hildebrandt MA, Lu C, Lin J, Gu J, Huang M, Lippman SM, Wu X. Genetic variations in the transforming growth factor-beta pathway as predictors of survival in advanced non-small cell lung cancer. Carcinogenesis. 2011 Jul; 32(7):1050-6. PMID: 21515830; PMCID: PMC3128559.
      Citations: 17     Fields:    Translation:Humans
    113. Wu X, Ye Y, Rosell R, Amos CI, Stewart DJ, Hildebrandt MA, Roth JA, Minna JD, Gu J, Lin J, Buch SC, Nukui T, Ramirez Serrano JL, Taron M, Cassidy A, Lu C, Chang JY, Lippman SM, Hong WK, Spitz MR, Romkes M, Yang P. Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy. J Natl Cancer Inst. 2011 May 18; 103(10):817-25. PMID: 21483023; PMCID: PMC3096796.
      Citations: 42     Fields:    Translation:Humans
    114. Gu J, Chen M, Shete S, Amos CI, Kamat A, Ye Y, Lin J, Dinney CP, Wu X. A genome-wide association study identifies a locus on chromosome 14q21 as a predictor of leukocyte telomere length and as a marker of susceptibility for bladder cancer. Cancer Prev Res (Phila). 2011 Apr; 4(4):514-21. PMID: 21460395; PMCID: PMC3076128.
      Citations: 34     Fields:    Translation:HumansCells
    115. Lee JJ, Wu X, Hildebrandt MA, Yang H, Khuri FR, Kim E, Gu J, Ye Y, Lotan R, Spitz MR, Hong WK. Global assessment of genetic variation influencing response to retinoid chemoprevention in head and neck cancer patients. Cancer Prev Res (Phila). 2011 Feb; 4(2):185-93. PMID: 21292633; PMCID: PMC3955084.
      Citations: 14     Fields:    Translation:HumansCTClinical Trials
    116. Purdue MP, Johansson M, Zelenika D, Toro JR, Scelo G, Moore LE, Prokhortchouk E, Wu X, Kiemeney LA, Gaborieau V, Jacobs KB, Chow WH, Zaridze D, Matveev V, Lubinski J, Trubicka J, Szeszenia-Dabrowska N, Lissowska J, Fabianova E, Bucur A, Bencko V, Foretova L, Janout V, Boffetta P, Colt JS, Davis FG, Schwartz KL, Banks RE, Selby PJ, Harnden P, Berg CD, Hsing AW, Grubb RL, Boeing H, Vineis P, Palli D, Tumino R, Krogh V, Panico S, Duell EJ, Navarro C, Ardanaz E, Dorronsoro M, Khaw KT, Allen NE, Bueno-de-Mesquita HB, Peeters PH, Trichopoulos D, Linseisen J, Overvad K, Romieu I, Riboli E, Mukeria A, Shangina O, Stevens VL, Thun MJ, Diver WR, Gapstur SM, Pharoah PD, Easton DF, Albanes D, Weinstein SJ, Virtamo J, Vatten L, Hveem K, Tell GS, Stoltenberg C, Kumar R, Koppova K, Cussenot O, Benhamou S, Oosterwijk E, Vermeulen SH, Aben KK, van der Marel SL, Ye Y, Wood CG, Pu X, Mazur AM, Boulygina ES, Chekanov NN, Foglio M, Lechner D, Gut I, Heath S, Hutchinson A, Thomas G, Wang Z, Yeager M, Fraumeni JF, Skryabin KG, McKay JD, Rothman N, Chanock SJ, Lathrop M, Brennan P, Rudnai P, Clavel-Chapelon F, Quir?s JR, Sanchez MJ, Ljungberg B, Tj?nneland A, Nj?lstad I, Blanche H. Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3. Nat Genet. 2011 Jan; 43(1):60-5. PMID: 21131975; PMCID: PMC3049257.
      Citations: 133     Fields:    Translation:HumansCells
    117. Kim SM, Park YY, Park ES, Cho JY, Izzo JG, Zhang D, Kim SB, Lee JH, Bhutani MS, Swisher SG, Wu X, Coombes KR, Maru D, Wang KK, Buttar NS, Ajani JA, Lee JS. Prognostic biomarkers for esophageal adenocarcinoma identified by analysis of tumor transcriptome. PLoS One. 2010 Nov 30; 5(11):e15074. PMID: 21152079; PMCID: PMC2994829.
      Citations: 77     Fields:    Translation:Humans
    118. Liang D, Meyer L, Chang DW, Lin J, Pu X, Ye Y, Gu J, Wu X, Lu K. Genetic variants in MicroRNA biosynthesis pathways and binding sites modify ovarian cancer risk, survival, and treatment response. Cancer Res. 2010 Dec 01; 70(23):9765-76. PMID: 21118967; PMCID: PMC5373101.
      Citations: 64     Fields:    Translation:HumansCells
    119. Gu J, Ye Y, Spitz MR, Lin J, Kiemeney LA, Xing J, Hildebrandt MA, Ki Hong W, Amos CI, Wu X. A genetic variant near the PMAIP1/Noxa gene is associated with increased bleomycin sensitivity. Hum Mol Genet. 2011 Feb 15; 20(4):820-6. PMID: 21106707; PMCID: PMC3024041.
      Citations: 5     Fields:    Translation:HumansCells
    120. Rothman N, Garcia-Closas M, Chatterjee N, Malats N, Wu X, Figueroa JD, Real FX, Van Den Berg D, Matullo G, Baris D, Thun M, Kiemeney LA, Vineis P, De Vivo I, Albanes D, Purdue MP, Rafnar T, Hildebrandt MA, Kiltie AE, Cussenot O, Golka K, Kumar R, Taylor JA, Mayordomo JI, Jacobs KB, Kogevinas M, Hutchinson A, Wang Z, Fu YP, Prokunina-Olsson L, Burdett L, Yeager M, Wheeler W, Serra C, Carrato A, Lloreta J, Johnson A, Schwenn M, Karagas MR, Schned A, Andriole G, Grubb R, Black A, Jacobs EJ, Diver WR, Gapstur SM, Weinstein SJ, Virtamo J, Cortessis VK, Gago-Dominguez M, Pike MC, Stern MC, Yuan JM, Hunter DJ, McGrath M, Dinney CP, Czerniak B, Chen M, Yang H, Vermeulen SH, Aben KK, Witjes JA, Makkinje RR, Sulem P, Besenbacher S, Stefansson K, Riboli E, Brennan P, Panico S, Navarro C, Allen NE, Bueno-de-Mesquita HB, Trichopoulos D, Caporaso N, Landi MT, Canzian F, Ljungberg B, Tjonneland A, Clavel-Chapelon F, Bishop DT, Teo MT, Knowles MA, Guarrera S, Polidoro S, Ricceri F, Sacerdote C, Allione A, Cancel-Tassin G, Selinski S, Hengstler JG, Dietrich H, Fletcher T, Rudnai P, Gurzau E, Koppova K, Bolick SC, Godfrey A, Xu Z, Sanchez M, Valdivia G, Porru S, Benhamou S, Hoover RN, Fraumeni JF, Silverman DT, Chanock SJ, Tard?n A, Garc?a-Closas R, Sanz-Velez JI, D Garc?a-Prats M. A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet. 2010 Nov; 42(11):978-84. PMID: 20972438; PMCID: PMC3049891.
      Citations: 226     Fields:    Translation:HumansCells
    121. Sigurdson AJ, Jones IM, Wei Q, Wu X, Spitz MR, Stram DA, Gross MD, Huang WY, Wang LE, Gu J, Thomas CB, Reding DJ, Hayes RB, Caporaso NE. Prospective analysis of DNA damage and repair markers of lung cancer risk from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Carcinogenesis. 2011 Jan; 32(1):69-73. PMID: 20929901; PMCID: PMC3010173.
      Citations: 13     Fields:    Translation:HumansCells
    122. Svatek RS, Shah JB, Xing J, Chang D, Lin J, McConkey DJ, Wu X, Dinney CP. A multiplexed, particle-based flow cytometric assay identified plasma matrix metalloproteinase-7 to be associated with cancer-related death among patients with bladder cancer. Cancer. 2010 Oct 01; 116(19):4513-9. PMID: 20572047.
      Citations: 17     Fields:    Translation:Humans
    123. Chen M, Hildebrandt MA, Clague J, Kamat AM, Picornell A, Chang J, Zhang X, Izzo J, Yang H, Lin J, Gu J, Chanock S, Kogevinas M, Rothman N, Silverman DT, Garcia-Closas M, Grossman HB, Dinney CP, Wu X, Malats N. Genetic variations in the sonic hedgehog pathway affect clinical outcomes in non-muscle-invasive bladder cancer. Cancer Prev Res (Phila). 2010 Oct; 3(10):1235-45. PMID: 20858759; PMCID: PMC2955764.
      Citations: 28     Fields:    Translation:Humans
    124. Zhang X, Yang H, Lee JJ, Kim E, Lippman SM, Khuri FR, Spitz MR, Lotan R, Hong WK, Wu X. MicroRNA-related genetic variations as predictors for risk of second primary tumor and/or recurrence in patients with early-stage head and neck cancer. Carcinogenesis. 2010 Dec; 31(12):2118-23. PMID: 20819778; PMCID: PMC3105587.
      Citations: 24     Fields:    Translation:Humans
    125. Hildebrandt MA, Komaki R, Liao Z, Gu J, Chang JY, Ye Y, Lu C, Stewart DJ, Minna JD, Roth JA, Lippman SM, Cox JD, Hong WK, Spitz MR, Wu X. Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer. PLoS One. 2010 Aug 25; 5(8):e12402. PMID: 20811626; PMCID: PMC2928273.
      Citations: 43     Fields:    Translation:HumansPHPublic Health
    126. Lin J, Horikawa Y, Tamboli P, Clague J, Wood CG, Wu X. Genetic variations in microRNA-related genes are associated with survival and recurrence in patients with renal cell carcinoma. Carcinogenesis. 2010 Oct; 31(10):1805-12. PMID: 20732906; PMCID: PMC2981457.
      Citations: 61     Fields:    Translation:Humans
    127. Hildebrandt MA, Gu J, Lin J, Ye Y, Tan W, Tamboli P, Wood CG, Wu X. Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma. Oncogene. 2010 Oct 21; 29(42):5724-8. PMID: 20676129.
      Citations: 91     Fields:    Translation:HumansCells
    128. Gu J, Ajani JA, Hawk ET, Ye Y, Lee JH, Bhutani MS, Hofstetter WL, Swisher SG, Wang KK, Wu X. Genome-wide catalogue of chromosomal aberrations in barrett's esophagus and esophageal adenocarcinoma: a high-density single nucleotide polymorphism array analysis. Cancer Prev Res (Phila). 2010 Sep; 3(9):1176-86. PMID: 20651033; PMCID: PMC3932797.
      Citations: 45     Fields:    Translation:Humans
    129. Wang J, Spitz MR, Amos CI, Wilkinson AV, Wu X, Shete S. Mediating effects of smoking and chronic obstructive pulmonary disease on the relation between the CHRNA5-A3 genetic locus and lung cancer risk. Cancer. 2010 Jul 15; 116(14):3458-62. PMID: 20564069; PMCID: PMC3073819.
      Citations: 41     Fields:    Translation:Humans
    130. Wang J, Lippman SM, Lee JJ, Yang H, Khuri FR, Kim E, Lin J, Chang DW, Lotan R, Hong WK, Wu X. Genetic variations in regulator of G-protein signaling genes as susceptibility loci for second primary tumor/recurrence in head and neck squamous cell carcinoma. Carcinogenesis. 2010 Oct; 31(10):1755-61. PMID: 20627871; PMCID: PMC2950933.
      Citations: 8     Fields:    Translation:Humans
    131. Liu Y, Shete S, Wang LE, El-Zein R, Etzel CJ, Liang FW, Armstrong G, Tsavachidis S, Gilbert MR, Aldape KD, Xing J, Wu X, Wei Q, Bondy ML. Gamma-radiation sensitivity and polymorphisms in RAD51L1 modulate glioma risk. Carcinogenesis. 2010 Oct; 31(10):1762-9. PMID: 20610542; PMCID: PMC2981459.
      Citations: 10     Fields:    Translation:Humans
    132. Amos CI, Gorlov IP, Dong Q, Wu X, Zhang H, Lu EY, Scheet P, Greisinger AJ, Mills GB, Spitz MR. Nicotinic acetylcholine receptor region on chromosome 15q25 and lung cancer risk among African Americans: a case-control study. J Natl Cancer Inst. 2010 Aug 04; 102(15):1199-205. PMID: 20554942; PMCID: PMC2914761.
      Citations: 41     Fields:    Translation:HumansCells
    133. Truong T, Hung RJ, Amos CI, Wu X, Rosenberger A, Sauter W, Illig T, Wichmann HE, Risch A, Dienemann H, Kaaks R, Yang P, Jiang R, Wiencke JK, Wrensch M, Hansen H, Kelsey KT, Matsuo K, Tajima K, Schwartz AG, Wenzlaff A, Seow A, Ying C, Staratschek-Jox A, Stoelben E, Lazarus P, Muscat JE, Gallagher CJ, Zienolddiny S, Haugen A, van der Heijden HF, Kiemeney LA, Isla D, Mayordomo JI, Rafnar T, Stefansson K, Zhang ZF, Chang SC, Kim JH, Hong YC, Duell EJ, Andrew AS, Lejbkowicz F, Rennert G, Brenner H, Benhamou S, Bouchardy C, Teare MD, Xue X, McLaughlin J, Liu G, McKay JD, Brennan P, Spitz MR, Bickeb?ller H, N?rnberg P, Wolf J, M?ller H, Le Marchand L. Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium. J Natl Cancer Inst. 2010 Jul 07; 102(13):959-71. PMID: 20548021; PMCID: PMC2897877.
      Citations: 104     Fields:    Translation:HumansCells
    134. Chen M, Gu J, Delclos GL, Killary AM, Fan Z, Hildebrandt MA, Chamberlain RM, Grossman HB, Dinney CP, Wu X. Genetic variations of the PI3K-AKT-mTOR pathway and clinical outcome in muscle invasive and metastatic bladder cancer patients. Carcinogenesis. 2010 Aug; 31(8):1387-91. PMID: 20530239; PMCID: PMC2915631.
      Citations: 29     Fields:    Translation:Humans
    135. Saeki N, Gu J, Yoshida T, Wu X. Prostate stem cell antigen: a Jekyll and Hyde molecule? Clin Cancer Res. 2010 Jul 15; 16(14):3533-8. PMID: 20501618; PMCID: PMC2905486.
      Citations: 76     Fields:    Translation:Humans
    136. Pu X, Hildebrandt MA, Lu C, Lin J, Stewart DJ, Ye Y, Gu J, Spitz MR, Wu X. PI3K/PTEN/AKT/mTOR pathway genetic variation predicts toxicity and distant progression in lung cancer patients receiving platinum-based chemotherapy. Lung Cancer. 2011 Jan; 71(1):82-8. PMID: 20447721; PMCID: PMC2952281.
      Citations: 31     Fields:    Translation:Humans
    137. Liu P, Yang P, Wu X, Vikis HG, Lu Y, Wang Y, Schwartz AG, Pinney SM, de Andrade M, Gazdar A, Gaba C, Mandal D, Lee J, Kupert E, Seminara D, Minna J, Bailey-Wilson JE, Spitz M, Amos CI, Anderson MW, You M. A second genetic variant on chromosome 15q24-25.1 associates with lung cancer. Cancer Res. 2010 Apr 15; 70(8):3128-35. PMID: 20395203; PMCID: PMC3378320.
      Citations: 3     Fields:    Translation:HumansCells
    138. Lin J, Wang J, Greisinger AJ, Grossman HB, Forman MR, Dinney CP, Hawk ET, Wu X. Energy balance, the PI3K-AKT-mTOR pathway genes, and the risk of bladder cancer. Cancer Prev Res (Phila). 2010 Apr; 3(4):505-17. PMID: 20354165; PMCID: PMC2867666.
      Citations: 15     Fields:    Translation:HumansCells
    139. Li Y, Sheu CC, Ye Y, de Andrade M, Wang L, Chang SC, Aubry MC, Aakre JA, Allen MS, Chen F, Cunningham JM, Deschamps C, Jiang R, Lin J, Marks RS, Pankratz VS, Su L, Li Y, Sun Z, Tang H, Vasmatzis G, Harris CC, Spitz MR, Jen J, Wang R, Zhang ZF, Christiani DC, Wu X, Yang P. Genetic variants and risk of lung cancer in never smokers: a genome-wide association study. Lancet Oncol. 2010 Apr; 11(4):321-30. PMID: 20304703; PMCID: PMC2945218.
      Citations: 107     Fields:    Translation:HumansCells
    140. Clague J, Lippman SM, Yang H, Hildebrandt MA, Ye Y, Lee JJ, Wu X. Genetic variation in MicroRNA genes and risk of oral premalignant lesions. Mol Carcinog. 2010 Feb; 49(2):183-9. PMID: 19851984; PMCID: PMC3640857.
      Citations: 47     Fields:    Translation:Humans
    141. Cassidy A, Wang W, Wu X, Lin J. Risk of urinary bladder cancer: a case-control analysis of industry and occupation. BMC Cancer. 2009 Dec 15; 9:443. PMID: 20003537; PMCID: PMC2803497.
      Citations: 14     Fields:    Translation:Humans
    142. Chen M, Cassidy A, Gu J, Delclos GL, Zhen F, Yang H, Hildebrandt MA, Lin J, Ye Y, Chamberlain RM, Dinney CP, Wu X. Genetic variations in PI3K-AKT-mTOR pathway and bladder cancer risk. Carcinogenesis. 2009 Dec; 30(12):2047-52. PMID: 19875696; PMCID: PMC2792319.
      Citations: 38     Fields:    Translation:Humans
    143. Wu X, Hildebrandt MA, Chang DW. Genome-wide association studies of bladder cancer risk: a field synopsis of progress and potential applications. Cancer Metastasis Rev. 2009 Dec; 28(3-4):269-80. PMID: 20016998.
      Citations: 19     Fields:    Translation:HumansCells
    144. Chen M, Ye Y, Yang H, Tamboli P, Matin S, Tannir NM, Wood CG, Gu J, Wu X. Genome-wide profiling of chromosomal alterations in renal cell carcinoma using high-density single nucleotide polymorphism arrays. Int J Cancer. 2009 Nov 15; 125(10):2342-8. PMID: 19521957; PMCID: PMC2768265.
      Citations: 38     Fields:    Translation:HumansCells
    145. Li DQ, Divijendra Natha Reddy S, Pakala SB, Wu X, Zhang Y, Rayala SK, Kumar R. MTA1 coregulator regulates p53 stability and function. J Biol Chem. 2009 Dec 11; 284(50):34545-52. PMID: 19837670; PMCID: PMC2787316.
      Citations: 28     Fields:    Translation:HumansAnimalsCells
    146. Clague J, Cinciripini P, Blalock J, Wu X, Hudmon KS. The D2 dopamine receptor gene and nicotine dependence among bladder cancer patients and controls. Behav Genet. 2010 Jan; 40(1):49-58. PMID: 19842028; PMCID: PMC3719969.
      Citations: 3     Fields:    Translation:Humans
    147. Reyes-Gibby CC, Spitz MR, Yennurajalingam S, Swartz M, Gu J, Wu X, Bruera E, Shete S. Role of inflammation gene polymorphisms on pain severity in lung cancer patients. Cancer Epidemiol Biomarkers Prev. 2009 Oct; 18(10):2636-42. PMID: 19773451; PMCID: PMC2759856.
      Citations: 27     Fields:    Translation:Humans
    148. Yang H, Gu J, Wang KK, Zhang W, Xing J, Chen Z, Ajani JA, Wu X. MicroRNA expression signatures in Barrett's esophagus and esophageal adenocarcinoma. Clin Cancer Res. 2009 Sep 15; 15(18):5744-52. PMID: 19737949; PMCID: PMC2745487.
      Citations: 68     Fields:    Translation:Humans
    149. Kiemeney LA, Grotenhuis AJ, Vermeulen SH, Wu X. Genome-wide association studies in bladder cancer: first results and potential relevance. Curr Opin Urol. 2009 Sep; 19(5):540-6. PMID: 19553824.
      Citations: 9     Fields:    Translation:Humans
    150. Stern MC, Lin J, Figueroa JD, Kelsey KT, Kiltie AE, Yuan JM, Matullo G, Fletcher T, Benhamou S, Taylor JA, Placidi D, Zhang ZF, Steineck G, Rothman N, Kogevinas M, Silverman D, Malats N, Chanock S, Wu X, Karagas MR, Andrew AS, Nelson HH, Bishop DT, Sak SC, Choudhury A, Barrett JH, Elliot F, Joshi AD, Gago-Dominguez M, Cortessis VK, Xiang YB, Gao YT, Vineis P, Sacerdote C, Guarrera S, Polidoro S, Allione A, Gurzau E, Koppova K, Kumar R, Rudnai P, Porru S, Carta A, Campagna M, Arici C, Park SS, Garcia-Closas M, International Consortium of Bladder Cancer, Corral R. Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the international consortium of bladder cancer. Cancer Res. 2009 Sep 01; 69(17):6857-64. PMID: 19706757; PMCID: PMC2782435.
      Citations: 55     Fields:    Translation:HumansCells
    151. Wu X, Ye Y, Kiemeney LA, Sulem P, Rafnar T, Matullo G, Seminara D, Yoshida T, Saeki N, Andrew AS, Dinney CP, Czerniak B, Zhang ZF, Kiltie AE, Bishop DT, Vineis P, Porru S, Buntinx F, Kellen E, Zeegers MP, Kumar R, Rudnai P, Gurzau E, Koppova K, Mayordomo JI, Sanchez M, Saez B, Lindblom A, de Verdier P, Steineck G, Mills GB, Schned A, Guarrera S, Polidoro S, Chang SC, Lin J, Chang DW, Hale KS, Majewski T, Grossman HB, Thorlacius S, Thorsteinsdottir U, Aben KK, Witjes JA, Stefansson K, Amos CI, Karagas MR, Gu J. Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer. Nat Genet. 2009 Sep; 41(9):991-5. PMID: 19648920; PMCID: PMC3313685.
      Citations: 122     Fields:    Translation:HumansCells
    152. Wu X, Spitz MR, Lee JJ, Lippman SM, Ye Y, Yang H, Khuri FR, Kim E, Gu J, Lotan R, Hong WK. Novel susceptibility loci for second primary tumors/recurrence in head and neck cancer patients: large-scale evaluation of genetic variants. Cancer Prev Res (Phila). 2009 Jul; 2(7):617-24. PMID: 19584075; PMCID: PMC2964280.
      Citations: 39     Fields:    Translation:Humans
    153. Hildebrandt MA, Gu J, Wu X. Pharmacogenomics of platinum-based chemotherapy in NSCLC. Expert Opin Drug Metab Toxicol. 2009 Jul; 5(7):745-55. PMID: 19442035; PMCID: PMC3417337.
      Citations: 31     Fields:    Translation:HumansAnimals
    154. Lin J, Kamat A, Gu J, Chen M, Dinney CP, Forman MR, Wu X. Dietary intake of vegetables and fruits and the modification effects of GSTM1 and NAT2 genotypes on bladder cancer risk. Cancer Epidemiol Biomarkers Prev. 2009 Jul; 18(7):2090-7. PMID: 19549811.
      Citations: 20     Fields:    Translation:HumansAnimals
    155. Tahara H, Sato M, Thurin M, Wang E, Butterfield LH, Disis ML, Fox BA, Lee PP, Khleif SN, Wigginton JM, Ambs S, Akutsu Y, Chaussabel D, Doki Y, Eremin O, Hirohashi Y, Imai K, Jacobson J, Jinushi M, Kanamoto A, Kashani-Sabet M, Kato K, Kawakami Y, Kirkwood JM, Kleen TO, Lehmann PV, Liotta L, Lotze MT, Maio M, Malyguine A, Masucci G, Matsubara H, Mayrand-Chung S, Nakamura K, Nishikawa H, Palucka AK, Petricoin EF, Pos Z, Ribas A, Rivoltini L, Sato N, Shiku H, Slingluff CL, Streicher H, Stroncek DF, Takeuchi H, Toyota M, Wada H, Wu X, Wulfkuhle J, Yaguchi T, Zeskind B, Zhao Y, Zocca MB, Marincola FM, Fridman WH. Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in Oncology. J Transl Med. 2009 Jun 17; 7:45. PMID: 19534815; PMCID: PMC2724494.
      Citations: 25     Fields:    Translation:Humans
    156. Cassidy A, Balsan J, Wu X, Liloglou T, Brambilla C, Field JK, EUELC Consortium, Vesin A, Timsit JF. Cancer diagnosis in first-degree relatives and non-small cell lung cancer risk: results from a multi-centre case-control study in Europe. Eur J Cancer. 2009 Nov; 45(17):3047-53. PMID: 19482469.
      Citations: 7     Fields:    Translation:HumansPHPublic Health
    157. Chen G, Izzo J, Demizu Y, Wang F, Guha S, Wu X, Hung MC, Ajani JA, Huang P. Different redox states in malignant and nonmalignant esophageal epithelial cells and differential cytotoxic responses to bile acid and honokiol. Antioxid Redox Signal. 2009 May; 11(5):1083-95. PMID: 19187006; PMCID: PMC2842128.
      Citations: 14     Fields:    Translation:HumansCells
    158. Xing J, Ajani JA, Chen M, Izzo J, Lin J, Chen Z, Gu J, Wu X. Constitutive short telomere length of chromosome 17p and 12q but not 11q and 2p is associated with an increased risk for esophageal cancer. Cancer Prev Res (Phila). 2009 May; 2(5):459-65. PMID: 19401529; PMCID: PMC2701666.
      Citations: 37     Fields:    Translation:HumansCells
    159. Pu X, Lippman SM, Yang H, Lee JJ, Wu X. Cyclooxygenase-2 gene polymorphisms reduce the risk of oral premalignant lesions. Cancer. 2009 Apr 01; 115(7):1498-506. PMID: 19197984; PMCID: PMC2666299.
      Citations: 10     Fields:    Translation:Humans
    160. Pan J, Lin J, Izzo JG, Liu Y, Xing J, Huang M, Ajani JA, Wu X. Genetic susceptibility to esophageal cancer: the role of the nucleotide excision repair pathway. Carcinogenesis. 2009 May; 30(5):785-92. PMID: 19270000; PMCID: PMC2675653.
      Citations: 44     Fields:    Translation:HumansCells
    161. Clague J, Lin J, Cassidy A, Matin S, Tannir NM, Tamboli P, Wood CG, Wu X. Family history and risk of renal cell carcinoma: results from a case-control study and systematic meta-analysis. Cancer Epidemiol Biomarkers Prev. 2009 Mar; 18(3):801-7. PMID: 19240244; PMCID: PMC2747496.
      Citations: 38     Fields:    Translation:Humans
    162. Clague J, Shao L, Lin J, Chang S, Zhu Y, Wang W, Wood CG, Wu X. Sensitivity to NNKOAc is associated with renal cancer risk. Carcinogenesis. 2009 Apr; 30(4):706-10. PMID: 19237609; PMCID: PMC2722144.
      Citations: 13     Fields:    Translation:HumansCells
    163. Hildebrandt MA, Yang H, Hung MC, Izzo JG, Huang M, Lin J, Ajani JA, Wu X. Genetic variations in the PI3K/PTEN/AKT/mTOR pathway are associated with clinical outcomes in esophageal cancer patients treated with chemoradiotherapy. J Clin Oncol. 2009 Feb 20; 27(6):857-71. PMID: 19164214; PMCID: PMC2738430.
      Citations: 80     Fields:    Translation:HumansCells
    164. Papadimitrakopoulou V, Izzo JG, Liu DD, Myers J, Ceron TL, Lewin J, William WN, Atwell A, Lee JJ, Gillenwater A, El-Naggar A, Wu X, Lippman SM, Hittelman WN, Hong WK. Cyclin D1 and cancer development in laryngeal premalignancy patients. Cancer Prev Res (Phila). 2009 Jan; 2(1):14-21. PMID: 19139013; PMCID: PMC4243520.
      Citations: 12     Fields:    Translation:Humans
    165. Butterfield LH, Disis ML, Fox BA, Lee PP, Khleif SN, Thurin M, Trinchieri G, Wang E, Wigginton J, Chaussabel D, Coukos G, Dhodapkar M, Janetzki S, Kleen TO, Kirkwood JM, Maccalli C, Maecker H, Maio M, Malyguine A, Masucci G, Palucka AK, Potter DM, Ribas A, Rivoltini L, Schendel D, Seliger B, Selvan S, Slingluff CL, Stroncek DF, Streicher H, Wu X, Zeskind B, Zhao Y, Zocca MB, Zwierzina H, Marincola FM, H?kansson L. A systematic approach to biomarker discovery; preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers". J Transl Med. 2008 Dec 23; 6:81. PMID: 19105846; PMCID: PMC2630944.
      Citations: 29     Fields:    Translation:Humans
    166. Horikawa Y, Wood CG, Yang H, Zhao H, Ye Y, Gu J, Lin J, Habuchi T, Wu X. Single nucleotide polymorphisms of microRNA machinery genes modify the risk of renal cell carcinoma. Clin Cancer Res. 2008 Dec 01; 14(23):7956-62. PMID: 19047128; PMCID: PMC2650498.
      Citations: 115     Fields:    Translation:Humans
    167. Izzo JG, Wu X, Wu TT, Huang P, Lee JS, Liao Z, Lee JH, Bhutani MS, Hofstetter W, Maru D, Hung MC, Ajani JA. Therapy-induced expression of NF-kappaB portends poor prognosis in patients with localized esophageal cancer undergoing preoperative chemoradiation. Dis Esophagus. 2009; 22(2):127-32. PMID: 19021681.
      Citations: 6     Fields:    Translation:Humans
    168. Wang Y, Broderick P, Webb E, Wu X, Vijayakrishnan J, Matakidou A, Qureshi M, Dong Q, Gu X, Chen WV, Spitz MR, Eisen T, Amos CI, Houlston RS. Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nat Genet. 2008 Dec; 40(12):1407-9. PMID: 18978787; PMCID: PMC2695928.
      Citations: 304     Fields:    Translation:HumansCells
    169. Reyes-Gibby CC, El Osta B, Spitz MR, Parsons H, Kurzrock R, Wu X, Shete S, Bruera E. The influence of tumor necrosis factor-alpha -308 G/A and IL-6 -174 G/C on pain and analgesia response in lung cancer patients receiving supportive care. Cancer Epidemiol Biomarkers Prev. 2008 Nov; 17(11):3262-7. PMID: 18990769; PMCID: PMC3398799.
      Citations: 24     Fields:    Translation:Humans
    170. Wu X, Lu C, Ye Y, Chang J, Yang H, Lin J, Gu J, Hong WK, Stewart D, Spitz MR. Germline genetic variations in drug action pathways predict clinical outcomes in advanced lung cancer treated with platinum-based chemotherapy. Pharmacogenet Genomics. 2008 Nov; 18(11):955-65. PMID: 18854777; PMCID: PMC2665725.
      Citations: 21     Fields:    Translation:HumansCells
    171. Ye Y, Wang KK, Gu J, Yang H, Lin J, Ajani JA, Wu X. Genetic variations in microRNA-related genes are novel susceptibility loci for esophageal cancer risk. Cancer Prev Res (Phila). 2008 Nov; 1(6):460-9. PMID: 19138993; PMCID: PMC2768267.
      Citations: 114     Fields:    Translation:Humans
    172. Ye Y, Lippman SM, Lee JJ, Chen M, Frazier ML, Spitz MR, Wu X. Genetic variations in cell-cycle pathway and the risk of oral premalignant lesions. Cancer. 2008 Nov 01; 113(9):2488-95. PMID: 18823025; PMCID: PMC2577230.
      Citations: 6     Fields:    Translation:Humans
    173. Wu X, Ros MM, Gu J, Kiemeney L. Epidemiology and genetic susceptibility to bladder cancer. BJU Int. 2008 Nov; 102(9 Pt B):1207-15. PMID: 19035883.
      Citations: 18     Fields:    Translation:HumansPHPublic Health
    174. Spitz MR, Amos CI, Dong Q, Lin J, Wu X. The CHRNA5-A3 region on chromosome 15q24-25.1 is a risk factor both for nicotine dependence and for lung cancer. J Natl Cancer Inst. 2008 Nov 05; 100(21):1552-6. PMID: 18957677; PMCID: PMC2720751.
      Citations: 135     Fields:    Translation:HumansCells
    175. Liu P, Vikis HG, Wang D, Lu Y, Wang Y, Schwartz AG, Pinney SM, Yang P, de Andrade M, Petersen GM, Wiest JS, Fain PR, Gazdar A, Gaba C, Rothschild H, Mandal D, Coons T, Lee J, Kupert E, Seminara D, Minna J, Bailey-Wilson JE, Wu X, Spitz MR, Eisen T, Houlston RS, Amos CI, Anderson MW, You M. Familial aggregation of common sequence variants on 15q24-25.1 in lung cancer. J Natl Cancer Inst. 2008 Sep 17; 100(18):1326-30. PMID: 18780872; PMCID: PMC2538550.
      Citations: 85     Fields:    Translation:HumansCells
    176. Massion PP, Zou Y, Chen H, Jiang A, Coulson P, Amos CI, Wu X, Wistuba I, Wei Q, Shyr Y, Spitz MR. Smoking-related genomic signatures in non-small cell lung cancer. Am J Respir Crit Care Med. 2008 Dec 01; 178(11):1164-72. PMID: 18776155; PMCID: PMC2720147.
      Citations: 17     Fields:    Translation:Humans
    177. Spitz MR, Etzel CJ, Dong Q, Amos CI, Wei Q, Wu X, Hong WK. An expanded risk prediction model for lung cancer. Cancer Prev Res (Phila). 2008 Sep; 1(4):250-4. PMID: 19138968; PMCID: PMC2854404.
      Citations: 61     Fields:    Translation:HumansCells
    178. Margulis V, Lin J, Yang H, Wang W, Wood CG, Wu X. Genetic susceptibility to renal cell carcinoma: the role of DNA double-strand break repair pathway. Cancer Epidemiol Biomarkers Prev. 2008 Sep; 17(9):2366-73. PMID: 18768505; PMCID: PMC2581835.
      Citations: 18     Fields:    Translation:Humans
    179. Gu J, Horikawa Y, Chen M, Dinney CP, Wu X. Benzo(a)pyrene diol epoxide-induced chromosome 9p21 aberrations are associated with increased risk of bladder cancer. Cancer Epidemiol Biomarkers Prev. 2008 Sep; 17(9):2445-50. PMID: 18768515.
      Citations: 6     Fields:    Translation:HumansCells
    180. Horikawa Y, Gu J, Wu X. Genetic susceptibility to bladder cancer with an emphasis on gene-gene and gene-environmental interactions. Curr Opin Urol. 2008 Sep; 18(5):493-8. PMID: 18670273.
      Citations: 9     Fields:    Translation:Humans
    181. Lin J, Pu X, Wang W, Matin S, Tannir NM, Wood CG, Wu X. Case-control analysis of nucleotide excision repair pathway and the risk of renal cell carcinoma. Carcinogenesis. 2008 Nov; 29(11):2112-9. PMID: 18711149; PMCID: PMC2722861.
      Citations: 11     Fields:    Translation:HumansCells
    182. Reyes-Gibby CC, Wu X, Spitz M, Kurzrock R, Fisch M, Bruera E, Shete S. Molecular epidemiology, cancer-related symptoms, and cytokines pathway. Lancet Oncol. 2008 Aug; 9(8):777-85. PMID: 18672213; PMCID: PMC3390774.
      Citations: 45     Fields:    Translation:Humans
    183. Xing J, Chen M, Wood CG, Lin J, Spitz MR, Ma J, Amos CI, Shields PG, Benowitz NL, Gu J, de Andrade M, Swan GE, Wu X. Mitochondrial DNA content: its genetic heritability and association with renal cell carcinoma. J Natl Cancer Inst. 2008 Aug 06; 100(15):1104-12. PMID: 18664653; PMCID: PMC2720693.
      Citations: 119     Fields:    Translation:HumansCells
    184. Yang H, Lippman SM, Huang M, Jack Lee J, Wang W, Spitz MR, Wu X. Genetic polymorphisms in double-strand break DNA repair genes associated with risk of oral premalignant lesions. Eur J Cancer. 2008 Jul; 44(11):1603-11. PMID: 18579371; PMCID: PMC2603619.
      Citations: 13     Fields:    Translation:HumansCells
    185. Xing J, Wu X, Vaporciyan AA, Spitz MR, Gu J. Prognostic significance of ataxia-telangiectasia mutated, DNA-dependent protein kinase catalytic subunit, and Ku heterodimeric regulatory complex 86-kD subunit expression in patients with nonsmall cell lung cancer. Cancer. 2008 Jun 15; 112(12):2756-64. PMID: 18457328; PMCID: PMC3384998.
      Citations: 29     Fields:    Translation:HumansCells
    186. Ye Y, Yang H, Grossman HB, Dinney C, Wu X, Gu J. Genetic variants in cell cycle control pathway confer susceptibility to bladder cancer. Cancer. 2008 Jun; 112(11):2467-74. PMID: 18361427.
      Citations: 28     Fields:    Translation:Humans
    187. Liang D, Lin J, Grossman HB, Ma J, Wei B, Dinney CP, Wu X. Plasma vitamins E and A and risk of bladder cancer: a case-control analysis. Cancer Causes Control. 2008 Nov; 19(9):981-92. PMID: 18478342.
      Citations: 11     Fields:    Translation:Humans
    188. Zhu Y, Horikawa Y, Yang H, Wood CG, Habuchi T, Wu X. BPDE induced lymphocytic chromosome 3p deletions may predict renal cell carcinoma risk. J Urol. 2008 Jun; 179(6):2416-21. PMID: 18433782; PMCID: PMC2810745.
      Citations: 4     Fields:    Translation:HumansCells
    189. Xing J, Stewart DJ, Gu J, Lu C, Spitz MR, Wu X. Expression of methylation-related genes is associated with overall survival in patients with non-small cell lung cancer. Br J Cancer. 2008 May 20; 98(10):1716-22. PMID: 18414412; PMCID: PMC2391117.
      Citations: 18     Fields:    Translation:HumansCells
    190. Amos CI, Wu X, Broderick P, Gorlov IP, Gu J, Eisen T, Dong Q, Zhang Q, Gu X, Vijayakrishnan J, Sullivan K, Matakidou A, Wang Y, Mills G, Doheny K, Tsai YY, Chen WV, Shete S, Spitz MR, Houlston RS. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet. 2008 May; 40(5):616-22. PMID: 18385676; PMCID: PMC2713680.
      Citations: 671     Fields:    Translation:HumansCells
    191. Yang H, Gu J, Lin X, Grossman HB, Ye Y, Dinney CP, Wu X. Profiling of genetic variations in inflammation pathway genes in relation to bladder cancer predisposition. Clin Cancer Res. 2008 Apr 01; 14(7):2236-44. PMID: 18381966.
      Citations: 26     Fields:    Translation:Humans
    192. Yang H, Dinney CP, Ye Y, Zhu Y, Grossman HB, Wu X. Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer. Cancer Res. 2008 Apr 01; 68(7):2530-7. PMID: 18381463.
      Citations: 128     Fields:    Translation:Humans
    193. Black PC, Brown GA, Inamoto T, Shrader M, Arora A, Siefker-Radtke AO, Adam L, Theodorescu D, Wu X, Munsell MF, Bar-Eli M, McConkey DJ, Dinney CP. Sensitivity to epidermal growth factor receptor inhibitor requires E-cadherin expression in urothelial carcinoma cells. Clin Cancer Res. 2008 Mar 01; 14(5):1478-86. PMID: 18316572.
      Citations: 45     Fields:    Translation:HumansAnimalsCells
    194. Hoque A, Goodman P, Ambrosone CB, Figg WD, Price DK, Kopp W, Wu X, Conroy J, Lehman TA, Santella RM. Extraction of DNA from serum for high-throughput genotyping: findings from pilot studies within the Prostate Cancer Prevention Trial. Urology. 2008 May; 71(5):967-70. PMID: 18267333; PMCID: PMC2387066.
      Citations: 3     Fields:    Translation:HumansCells
    195. Reyes-Gibby CC, Spitz M, Wu X, Merriman K, Etzel C, Bruera E, Kurzrock R, Shete S. Cytokine genes and pain severity in lung cancer: exploring the influence of TNF-alpha-308 G/A IL6-174G/C and IL8-251T/A. Cancer Epidemiol Biomarkers Prev. 2007 Dec; 16(12):2745-51. PMID: 18086782.
      Citations: 30     Fields:    Translation:Humans
    196. Zhu Y, Hoffman A, Wu X, Zhang H, Zhang Y, Leaderer D, Zheng T. Correlating observed odds ratios from lung cancer case-control studies to SNP functional scores predicted by bioinformatic tools. Mutat Res. 2008 Mar 01; 639(1-2):80-8. PMID: 18191955; PMCID: PMC2292456.
      Citations: 5     Fields:    
    197. Yang H, Spitz MR, Stewart DJ, Lu C, Gorlov IP, Wu X. ATM sequence variants associate with susceptibility to non-small cell lung cancer. Int J Cancer. 2007 Nov 15; 121(10):2254-9. PMID: 17582598; PMCID: PMC3477817.
      Citations: 17     Fields:    Translation:HumansCells
    198. Wu X, Lin J, Grossman HB, Huang M, Gu J, Etzel CJ, Amos CI, Dinney CP, Spitz MR. Projecting individualized probabilities of developing bladder cancer in white individuals. J Clin Oncol. 2007 Nov 01; 25(31):4974-81. PMID: 17971596.
      Citations: 32     Fields:    Translation:Humans
    199. Zhu Y, Yang H, Chen Q, Lin J, Grossman HB, Dinney CP, Wu X, Gu J. Modulation of DNA damage/DNA repair capacity by XPC polymorphisms. DNA Repair (Amst). 2008 Feb 01; 7(2):141-8. PMID: 17923445; PMCID: PMC2254649.
      Citations: 27     Fields:    Translation:HumansCells
    200. Lin J, Swan GE, Shields PG, Benowitz NL, Gu J, Amos CI, de Andrade M, Spitz MR, Wu X. Mutagen sensitivity and genetic variants in nucleotide excision repair pathway: genotype-phenotype correlation. Cancer Epidemiol Biomarkers Prev. 2007 Oct; 16(10):2065-71. PMID: 17932354.
      Citations: 24     Fields:    Translation:HumansCells
    201. Wang W, Spitz MR, Yang H, Lu C, Stewart DJ, Wu X. Genetic variants in cell cycle control pathway confer susceptibility to lung cancer. Clin Cancer Res. 2007 Oct 01; 13(19):5974-81. PMID: 17908995.
      Citations: 36     Fields:    Translation:Humans
    202. Saldivar JS, Wu X, Follen M, Gershenson D. Nucleotide excision repair pathway review I: implications in ovarian cancer and platinum sensitivity. Gynecol Oncol. 2007 Oct; 107(1 Suppl 1):S56-71. PMID: 17884153.
      Citations: 20     Fields:    Translation:HumansCells
    203. Saldivar JS, Lu KH, Liang D, Gu J, Huang M, Vlastos AT, Follen M, Wu X. Moving toward individualized therapy based on NER polymorphisms that predict platinum sensitivity in ovarian cancer patients. Gynecol Oncol. 2007 Oct; 107(1 Suppl 1):S223-9. PMID: 17825393.
      Citations: 12     Fields:    Translation:HumansCells
    204. Leibovici D, Kassouf W, Pisters LL, Pettaway CA, Wu X, Dinney CP, Grossman HB. Organ preservation for muscle-invasive bladder cancer by transurethral resection. Urology. 2007 Sep; 70(3):473-6. PMID: 17905099.
      Citations: 10     Fields:    Translation:Humans
    205. Chen M, Kamat AM, Huang M, Grossman HB, Dinney CP, Lerner SP, Wu X, Gu J. High-order interactions among genetic polymorphisms in nucleotide excision repair pathway genes and smoking in modulating bladder cancer risk. Carcinogenesis. 2007 Oct; 28(10):2160-5. PMID: 17728339.
      Citations: 29     Fields:    Translation:HumansCells
    206. Lee S, Jeong J, Majewski T, Scherer SE, Kim MS, Tuziak T, Tang KS, Baggerly K, Grossman HB, Zhou JH, Shen L, Bondaruk J, Ahmed SS, Samanta S, Spiess P, Wu X, Filipek S, McConkey D, Bar-Eli M, Issa JP, Benedict WF, Czerniak B. Forerunner genes contiguous to RB1 contribute to the development of in situ neoplasia. Proc Natl Acad Sci U S A. 2007 Aug 21; 104(34):13732-7. PMID: 17702869; PMCID: PMC1949496.
      Citations: 21     Fields:    Translation:HumansCells
    207. Shao L, Wood CG, Zhang D, Tannir NM, Matin S, Dinney CP, Wu X. Telomere dysfunction in peripheral lymphocytes as a potential predisposition factor for renal cancer. J Urol. 2007 Oct; 178(4 Pt 1):1492-6. PMID: 17707063.
      Citations: 44     Fields:    Translation:HumansCells
    208. Lin EH, Hassan M, Li Y, Zhao H, Nooka A, Sorenson E, Xie K, Champlin R, Wu X, Li D. Elevated circulating endothelial progenitor marker CD133 messenger RNA levels predict colon cancer recurrence. Cancer. 2007 Aug 01; 110(3):534-42. PMID: 17594720.
      Citations: 35     Fields:    Translation:HumansCells
    209. Lin X, Wood CG, Shao L, Huang M, Yang H, Dinney CP, Wu X. Risk assessment of renal cell carcinoma using alkaline comet assay. Cancer. 2007 Jul 15; 110(2):282-8. PMID: 17549681.
      Citations: 3     Fields:    Translation:Humans
    210. Xing J, Spitz MR, Lu C, Zhao H, Yang H, Wang W, Stewart DJ, Wu X. Deficient G2-M and S checkpoints are associated with increased lung cancer risk: a case-control analysis. Cancer Epidemiol Biomarkers Prev. 2007 Jul; 16(7):1517-22. PMID: 17627019.
      Citations: 10     Fields:    Translation:HumansCells
    211. Engels EA, Wu X, Gu J, Dong Q, Liu J, Spitz MR. Systematic evaluation of genetic variants in the inflammation pathway and risk of lung cancer. Cancer Res. 2007 Jul 01; 67(13):6520-7. PMID: 17596594.
      Citations: 77     Fields:    Translation:Humans
    212. Milam MR, Gu J, Yang H, Celestino J, Wu W, Horwitz IB, Lacour RA, Westin SN, Gershenson DM, Wu X, Lu KH. STK15 F31I polymorphism is associated with increased uterine cancer risk: a pilot study. Gynecol Oncol. 2007 Oct; 107(1):71-4. PMID: 17599395.
      Citations: 12     Fields:    Translation:Humans
    213. Jhamb M, Lin J, Ballow R, Kamat AM, Grossman HB, Wu X. Urinary tract diseases and bladder cancer risk: a case-control study. Cancer Causes Control. 2007 Oct; 18(8):839-45. PMID: 17593531.
      Citations: 11     Fields:    Translation:Humans
    214. Wang Y, Spitz MR, Lee JJ, Huang M, Lippman SM, Wu X. Nucleotide excision repair pathway genes and oral premalignant lesions. Clin Cancer Res. 2007 Jun 15; 13(12):3753-8. PMID: 17575242.
      Citations: 33     Fields:    Translation:HumansCells
    215. Wu X, Lin J, Etzel CJ, Dong Q, Gorlova OY, Zhang Q, Amos CI, Spitz MR. Interplay between mutagen sensitivity and epidemiological factors in modulatinglung cancer risk. Int J Cancer. 2007 Jun 15; 120(12):2687-95. PMID: 17290394.
      Citations: 14     Fields:    Translation:Humans
    216. Zhao H, Lin J, Grossman HB, Hernandez LM, Dinney CP, Wu X. Dietary isothiocyanates, GSTM1, GSTT1, NAT2 polymorphisms and bladder cancer risk. Int J Cancer. 2007 May 15; 120(10):2208-13. PMID: 17290402.
      Citations: 26     Fields:    Translation:Humans
    217. Spitz MR, Hong WK, Amos CI, Wu X, Schabath MB, Dong Q, Shete S, Etzel CJ. A risk model for prediction of lung cancer. J Natl Cancer Inst. 2007 May 02; 99(9):715-26. PMID: 17470739.
      Citations: 161     Fields:    Translation:Humans
    218. Kader AK, Liu J, Shao L, Dinney CP, Lin J, Wang Y, Gu J, Grossman HB, Wu X. Matrix metalloproteinase polymorphisms are associated with bladder cancer invasiveness. Clin Cancer Res. 2007 May 01; 13(9):2614-20. PMID: 17473191.
      Citations: 24     Fields:    Translation:HumansCells
    219. Wu X, Gu J, Spitz MR. Mutagen sensitivity: a genetic predisposition factor for cancer. Cancer Res. 2007 Apr 15; 67(8):3493-5. PMID: 17440053.
      Citations: 31     Fields:    Translation:Humans
    220. Kamat AM, Wu X. Statins and the effect of BCG on bladder cancer. N Engl J Med. 2007 Mar 22; 356(12):1276; author reply 1276-7. PMID: 17377172.
      Citations: 6     Fields:    Translation:Humans
    221. Chen M, Gu J, Xing J, Spitz MR, Wu X. Irradiation-induced telomerase activity and the risk of lung cancer: a pilot case-control study. Cancer. 2007 Mar 15; 109(6):1157-63. PMID: 17265522.
      Citations: 2     Fields:    Translation:HumansCells
    222. Xing J, Zhu Y, Zhao H, Yang H, Chen M, Spitz MR, Wu X. Differential induction in telomerase activity among bladder cancer patients and controls on gamma-radiation. Cancer Epidemiol Biomarkers Prev. 2007 Mar; 16(3):606-9. PMID: 17372259.
      Citations: 4     Fields:    Translation:Humans
    223. Izzo JG, Wu TT, Wu X, Ensor J, Luthra R, Pan J, Correa A, Swisher SG, Chao CK, Hittelman WN, Ajani JA. Cyclin D1 guanine/adenine 870 polymorphism with altered protein expression is associated with genomic instability and aggressive clinical biology of esophageal adenocarcinoma. J Clin Oncol. 2007 Feb 20; 25(6):698-707. PMID: 17308274.
      Citations: 22     Fields:    Translation:Humans
    224. Taioli E, Benhamou S, Bouchardy C, Cascorbi I, Cajas-Salazar N, Dally H, Fong KM, Larsen JE, Le Marchand L, London SJ, Risch A, Spitz MR, Stucker I, Weinshenker B, Wu X, Yang P. Myeloperoxidase G-463A polymorphism and lung cancer: a HuGE genetic susceptibility to environmental carcinogens pooled analysis. Genet Med. 2007 Feb; 9(2):67-73. PMID: 17304047.
      Citations: 23     Fields:    Translation:HumansCells
    225. Wu X, Lin X, Dinney CP, Gu J, Grossman HB. Genetic polymorphism in bladder cancer. Front Biosci. 2007 Jan 01; 12:192-213. PMID: 17127293.
      Citations: 10     Fields:    Translation:HumansCells
    226. Huang M, Dinney CP, Lin X, Lin J, Grossman HB, Wu X. High-order interactions among genetic variants in DNA base excision repair pathway genes and smoking in bladder cancer susceptibility. Cancer Epidemiol Biomarkers Prev. 2007 Jan; 16(1):84-91. PMID: 17220334.
      Citations: 44     Fields:    Translation:HumansCells
    227. Kader AK, Shao L, Dinney CP, Schabath MB, Wang Y, Liu J, Gu J, Grossman HB, Wu X. Matrix metalloproteinase polymorphisms and bladder cancer risk. Cancer Res. 2006 Dec 15; 66(24):11644-8. PMID: 17178858.
      Citations: 35     Fields:    Translation:Humans
    228. Gu J, Berman D, Lu C, Wistuba II, Roth JA, Frazier M, Spitz MR, Wu X. Aberrant promoter methylation profile and association with survival in patients with non-small cell lung cancer. Clin Cancer Res. 2006 Dec 15; 12(24):7329-38. PMID: 17189404.
      Citations: 34     Fields:    Translation:HumansCells
    229. Wu X, Gu J, Dong Q, Huang M, Do KA, Hong WK, Spitz MR. Joint effect of mutagen sensitivity and insulin-like growth factors in predicting the risk of developing secondary primary tumors and tumor recurrence in patients with head and neck cancer. Clin Cancer Res. 2006 Dec 01; 12(23):7194-201. PMID: 17145846.
      Citations: 8     Fields:    Translation:HumansCells
    230. Zhu Y, Lai M, Yang H, Lin J, Huang M, Grossman HB, Dinney CP, Wu X. Genotypes, haplotypes and diplotypes of XPC and risk of bladder cancer. Carcinogenesis. 2007 Mar; 28(3):698-703. PMID: 17052994.
      Citations: 21     Fields:    Translation:Humans
    231. Shao L, Hittelman WN, Lin J, Yang H, Ajani JA, Wu X. Deficiency of cell cycle checkpoints and DNA repair system predispose individuals to esophageal cancer. Mutat Res. 2006 Dec 01; 602(1-2):143-50. PMID: 17011594.
      Citations: 2     Fields:    Translation:HumansCells
    232. Lin X, Gu J, Lu C, Spitz MR, Wu X. Expression of telomere-associated genes as prognostic markers for overall survival in patients with non-small cell lung cancer. Clin Cancer Res. 2006 Oct 01; 12(19):5720-5. PMID: 17020976.
      Citations: 19     Fields:    Translation:HumansCells
    233. Chao DL, Maley CC, Wu X, Farrow DC, Galipeau PC, Sanchez CA, Paulson TG, Rabinovitch PS, Reid BJ, Spitz MR, Vaughan TL. Mutagen sensitivity and neoplastic progression in patients with Barrett's esophagus: a prospective analysis. Cancer Epidemiol Biomarkers Prev. 2006 Oct; 15(10):1935-40. PMID: 17035402.
      Citations: 11     Fields:    Translation:HumansCells
    234. Lin J, Dinney CP, Grossman HB, Jhamb M, Zhu Y, Spitz MR, Wu X. E-cadherin promoter polymorphism (C-160A) and risk of recurrence in patients with superficial bladder cancer. Clin Genet. 2006 Sep; 70(3):240-5. PMID: 16922727.
      Citations: 5     Fields:    Translation:HumansCells
    235. Lin J, Dinney CP, Grossman HB, Wu X. Personal permanent hair dye use is not associated with bladder cancer risk: evidence from a case-control study. Cancer Epidemiol Biomarkers Prev. 2006 Sep; 15(9):1746-9. PMID: 16985040.
      Citations: 8     Fields:    Translation:Humans
    236. Gu J, Gong Y, Huang M, Lu C, Spitz MR, Wu X. Polymorphisms of STK15 (Aurora-A) gene and lung cancer risk in Caucasians. Carcinogenesis. 2007 Feb; 28(2):350-5. PMID: 16926177.
      Citations: 21     Fields:    Translation:HumansCells
    237. Lin J, Spitz MR, Dinney CP, Etzel CJ, Grossman HB, Wu X. Bladder cancer risk as modified by family history and smoking. Cancer. 2006 Aug 15; 107(4):705-11. PMID: 16845665.
      Citations: 9     Fields:    Translation:Humans
    238. Wu X, Gu J, Wu TT, Swisher SG, Liao Z, Correa AM, Liu J, Etzel CJ, Amos CI, Huang M, Chiang SS, Milas L, Hittelman WN, Ajani JA. Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer. J Clin Oncol. 2006 Aug 10; 24(23):3789-98. PMID: 16785472.
      Citations: 62     Fields:    Translation:Humans
    239. Minard CG, Spitz MR, Wu X, Hong WK, Etzel CJ. Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer. Cancer. 2006 Jun 15; 106(12):2636-44. PMID: 16703596.
      Citations: 14     Fields:    Translation:Humans
    240. Wu X, Spitz MR, Amos CI, Lin J, Shao L, Gu J, de Andrade M, Benowitz NL, Shields PG, Swan GE. Mutagen sensitivity has high heritability: evidence from a twin study. Cancer Res. 2006 Jun 15; 66(12):5993-6. PMID: 16778168.
      Citations: 28     Fields:    Translation:HumansCells
    241. Gu J, Wu X, Dong Q, Romeo MJ, Lin X, Gutkind JS, Berman DM. A nonsynonymous single-nucleotide polymorphism in the PDZ-Rho guanine nucleotide exchange factor (Ser1416Gly) modulates the risk of lung cancer in Mexican Americans. Cancer. 2006 Jun 15; 106(12):2716-24. PMID: 16691626.
      Citations: 10     Fields:    Translation:HumansCells
    242. Cinciripini PM, Robinson JD, Carter BL, Lam C, Wu X, de Moor CA, Baile WF, Wetter DW. The effects of smoking deprivation and nicotine administration on emotional reactivity. Nicotine Tob Res. 2006 Jun; 8(3):379-92. PMID: 16801296.
      Citations: 37     Fields:    Translation:Humans
    243. Huang M, Spitz MR, Gu J, Lee JJ, Lin J, Lippman SM, Wu X. Cyclin D1 gene polymorphism as a risk factor for oral premalignant lesions. Carcinogenesis. 2006 Oct; 27(10):2034-7. PMID: 16638786.
      Citations: 22     Fields:    Translation:Humans
    244. Wu X, Gu J, Grossman HB, Amos CI, Etzel C, Huang M, Zhang Q, Millikan RE, Lerner S, Dinney CP, Spitz MR. Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes. Am J Hum Genet. 2006 Mar; 78(3):464-79. PMID: 16465622; PMCID: PMC1380289.
      Citations: 124     Fields:    Translation:HumansCells
    245. Lu C, Spitz MR, Zhao H, Dong Q, Truong M, Chang JY, Blumenschein GR, Hong WK, Wu X. Association between glutathione S-transferase pi polymorphisms and survival in patients with advanced nonsmall cell lung carcinoma. Cancer. 2006 Jan 15; 106(2):441-7. PMID: 16342067.
      Citations: 25     Fields:    Translation:Humans
    246. Schabath MB, Wu X, Wei Q, Li G, Gu J, Spitz MR. Combined effects of the p53 and p73 polymorphisms on lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2006 Jan; 15(1):158-61. PMID: 16434604.
      Citations: 16     Fields:    Translation:Humans
    247. Shao L, Lin J, Huang M, Ajani JA, Wu X. Predictors of esophageal cancer risk: assessment of susceptibility to DNA damage using comet assay. Genes Chromosomes Cancer. 2005 Dec; 44(4):415-22. PMID: 16114035.
      Citations: 5     Fields:    Translation:HumansCells
    248. Wu X, Lu C, Chiang SS, Ajani JA. Pharmacogenetics in esophageal cancer. Semin Oncol. 2005 Dec; 32(6 Suppl 9):S87-9. PMID: 16399440.
      Citations: 1     Fields:    Translation:Humans
    249. Zhao H, Liang D, Grossman HB, Wu X. Glutathione peroxidase 1 gene polymorphism and risk of recurrence in patients with superficial bladder cancer. Urology. 2005 Oct; 66(4):769-74. PMID: 16230136.
      Citations: 23     Fields:    Translation:Humans
    250. Schabath MB, Hernandez LM, Wu X, Pillow PC, Spitz MR. Dietary phytoestrogens and lung cancer risk. JAMA. 2005 Sep 28; 294(12):1493-504. PMID: 16189362.
      Citations: 29     Fields:    Translation:Humans
    251. Gu J, Grossman HB, Dinney CP, Wu X. The pharmacogenetic impact of inflammatory genes on bladder cancer recurrence. Pharmacogenomics. 2005 Sep; 6(6):575-84. PMID: 16142998.
      Citations: 8     Fields:    Translation:Humans
    252. Leibovici D, Grossman HB, Dinney CP, Millikan RE, Lerner S, Wang Y, Gu J, Dong Q, Wu X. Polymorphisms in inflammation genes and bladder cancer: from initiation to recurrence, progression, and survival. J Clin Oncol. 2005 Aug 20; 23(24):5746-56. PMID: 16110031.
      Citations: 57     Fields:    Translation:Humans
    253. Raimondi S, Boffetta P, Anttila S, Butkiewicz D, Cascorbi I, Clapper ML, Dragani TA, Garte S, Gsur A, Haidinger G, Hirvonen A, Ingelman-Sundberg M, Kalina I, Lan Q, Leoni VP, London SJ, Neri M, Povey AC, Rannug A, Reszka E, Ryberg D, Risch A, Romkes M, Ruano-Ravina A, Schoket B, Spinola M, Sugimura H, Wu X, Taioli E, Br?ckmoller J, Le Marchand L. Metabolic gene polymorphisms and lung cancer risk in non-smokers. An update of the GSEC study. Mutat Res. 2005 Dec 30; 592(1-2):45-57. PMID: 16009381.
      Citations: 14     Fields:    Translation:HumansPHPublic Health
    254. Lin J, Kadlubar FF, Spitz MR, Zhao H, Wu X. A modified host cell reactivation assay to measure DNA repair capacity for removing 4-aminobiphenyl adducts: a pilot study of bladder cancer. Cancer Epidemiol Biomarkers Prev. 2005 Jul; 14(7):1832-6. PMID: 16030125.
      Citations: 11     Fields:    Translation:HumansCells
    255. Zhao H, Grossman HB, Delclos GL, Hwang LY, Troisi CL, Chamberlain RM, Chenoweth MA, Zhang H, Spitz MR, Wu X. Increased plasma levels of angiogenin and the risk of bladder carcinoma: from initiation ot recurrence. Cancer. 2005 Jul 01; 104(1):30-5. PMID: 15912517.
      Citations: 11     Fields:    Translation:Humans
    256. Gu J, Spitz MR, Zhao H, Lin J, Grossman HB, Dinney CP, Wu X. Roles of tumor suppressor and telomere maintenance genes in cancer and aging--an epidemiological study. Carcinogenesis. 2005 Oct; 26(10):1741-7. PMID: 15905204.
      Citations: 8     Fields:    Translation:HumansCells
    257. Shaw AD, Vaporciyan AA, Wu X, King TM, Spitz MR, Putnam JB, Dickey BF. Inflammatory gene polymorphisms influence risk of postoperative morbidity after lung resection. Ann Thorac Surg. 2005 May; 79(5):1704-10. PMID: 15854959.
      Citations: 10     Fields:    Translation:Humans
    258. Chang JY, Komaki R, Sasaki R, Liao Z, Stevens CW, Lu C, Fossella FV, Allen PK, Cox JD, Spitz MR, Wu X. High mutagen sensitivity in peripheral blood lymphocytes predicts poor overall and disease-specific survival in patients with stage III non-small cell lung cancer treated with radiotherapy and chemotherapy. Clin Cancer Res. 2005 Apr 15; 11(8):2894-8. PMID: 15837739.
      Citations: 1     Fields:    Translation:HumansCells
    259. Saldivar SJ, Wang Y, Zhao H, Shao L, Lin J, Spitz MR, Wu X. An association between a NQO1 genetic polymorphism and risk of lung cancer. Mutat Res. 2005 Apr 04; 582(1-2):71-8. PMID: 15781212.
      Citations: 12     Fields:    Translation:HumansCells
    260. Schabath MB, Delclos GL, Grossman HB, Wang Y, Lerner SP, Chamberlain RM, Spitz MR, Wu X. Polymorphisms in XPD exons 10 and 23 and bladder cancer risk. Cancer Epidemiol Biomarkers Prev. 2005 Apr; 14(4):878-84. PMID: 15824159.
      Citations: 13     Fields:    Translation:Humans
    261. Komaki R, Chang JY, Wu X, Allen PK, Milas L, Liao Z, Fossella FV, Travis E, Spitz MR. Mutagen sensitivity may predict lung protection by amifostine for patients with locally advanced non-small cell lung cancer treated by chemoradiotherapy. Semin Oncol. 2005 Apr; 32(2 Suppl 3):S92-8. PMID: 16015542.
      Citations:    Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    262. Schabath MB, Delclos GL, Martynowicz MM, Greisinger AJ, Lu C, Wu X, Spitz MR. Opposing effects of emphysema, hay fever, and select genetic variants on lung cancer risk. Am J Epidemiol. 2005 Mar 01; 161(5):412-22. PMID: 15718477.
      Citations: 32     Fields:    Translation:Humans
    263. Gu J, Zhao H, Dinney CP, Zhu Y, Leibovici D, Bermejo CE, Grossman HB, Wu X. Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer. Clin Cancer Res. 2005 Feb 15; 11(4):1408-15. PMID: 15746040.
      Citations: 36     Fields:    Translation:HumansCells
    264. Spitz MR, Wu X, Mills G. Integrative epidemiology: from risk assessment to outcome prediction. J Clin Oncol. 2005 Jan 10; 23(2):267-75. PMID: 15637390.
      Citations: 20     Fields:    Translation:HumansPHPublic Health
    265. Wu X, Roth JA, Zhao H, Luo S, Zheng YL, Chiang S, Spitz MR. Cell cycle checkpoints, DNA damage/repair, and lung cancer risk. Cancer Res. 2005 Jan 01; 65(1):349-57. PMID: 15665313.
      Citations: 11     Fields:    Translation:HumansCells
    266. Schabath MB, Spitz MR, Lerner SP, Pillow PC, Hernandez LM, Delclos GL, Grossman HB, Wu X. Case-control analysis of dietary folate and risk of bladder cancer. Nutr Cancer. 2005; 53(2):144-51. PMID: 16573375.
      Citations: 8     Fields:    Translation:HumansAnimals
    267. Wu X, Zheng YL, Hsu TC. Mutagen-induced chromatid breakage as a marker of cancer risk. Methods Mol Biol. 2005; 291:59-67. PMID: 15502212.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    268. Gu J, Liang D, Wang Y, Lu C, Wu X. Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians. Mutat Res. 2005 Mar 07; 581(1-2):97-104. PMID: 15725609.
      Citations: 29     Fields:    Translation:HumansCells
    269. Do KA, Johnson MM, Lee JJ, Wu XF, Dong Q, Hong WK, Khuri FR, Spitz MR. Longitudinal study of smoking patterns in relation to the development of smoking-related secondary primary tumors in patients with upper aerodigestive tract malignancies. Cancer. 2004 Dec 15; 101(12):2837-42. PMID: 15536619.
      Citations: 34     Fields:    Translation:Humans
    270. Schabath MB, Grossman HB, Delclos GL, Hernandez LM, Day RS, Davis BR, Lerner SP, Spitz MR, Wu X. Dietary carotenoids and genetic instability modify bladder cancer risk. J Nutr. 2004 Dec; 134(12):3362-9. PMID: 15570038.
      Citations: 9     Fields:    Translation:HumansCells
    271. Franco EL, Correa P, Santella RM, Wu X, Goodman SN, Petersen GM. Role and limitations of epidemiology in establishing a causal association. Semin Cancer Biol. 2004 Dec; 14(6):413-26. PMID: 15489134.
      Citations: 7     Fields:    Translation:HumansCells
    272. Shao L, Lerner SL, Bondaruk J, Czerniak BA, Zeng X, Grossman HB, Spitz MR, Wu X. Specific chromosome aberrations in peripheral blood lymphocytes are associated with risk of bladder cancer. Genes Chromosomes Cancer. 2004 Dec; 41(4):379-89. PMID: 15390184.
      Citations: 1     Fields:    Translation:HumansCells
    273. Hazra A, Grossman HB, Zhu Y, Luo S, Spitz MR, Wu X. Benzo[a]pyrene diol epoxide-induced 9p21 aberrations associated with genetic predisposition to bladder cancer. Genes Chromosomes Cancer. 2004 Dec; 41(4):330-8. PMID: 15390186.
      Citations: 3     Fields:    Translation:HumansCells
    274. Berman DM, Wang Y, Liu Z, Dong Q, Burke LA, Liotta LA, Fisher R, Wu X. A functional polymorphism in RGS6 modulates the risk of bladder cancer. Cancer Res. 2004 Sep 15; 64(18):6820-6. PMID: 15375002.
      Citations: 28     Fields:    Translation:Humans
    275. Wu X, Zhao H, Suk R, Christiani DC. Genetic susceptibility to tobacco-related cancer. Oncogene. 2004 Aug 23; 23(38):6500-23. PMID: 15322521.
      Citations: 45     Fields:    Translation:HumansCells
    276. Rebbeck TR, Spitz M, Wu X. Assessing the function of genetic variants in candidate gene association studies. Nat Rev Genet. 2004 Aug; 5(8):589-97. PMID: 15266341.
      Citations: 48     Fields:    Translation:HumansCells
    277. Dinney CP, McConkey DJ, Millikan RE, Wu X, Bar-Eli M, Adam L, Kamat AM, Siefker-Radtke AO, Tuziak T, Sabichi AL, Grossman HB, Benedict WF, Czerniak B. Focus on bladder cancer. Cancer Cell. 2004 Aug; 6(2):111-6. PMID: 15324694.
      Citations: 134     Fields:    Translation:HumansAnimalsCells
    278. Wu X, Zhao H, Do KA, Johnson MM, Dong Q, Hong WK, Spitz MR. Serum levels of insulin growth factor (IGF-I) and IGF-binding protein predict risk of second primary tumors in patients with head and neck cancer. Clin Cancer Res. 2004 Jun 15; 10(12 Pt 1):3988-95. PMID: 15217929.
      Citations: 27     Fields:    Translation:HumansCTClinical Trials
    279. Zhu Y, Spitz MR, Zhang H, Grossman HB, Frazier ML, Wu X. Methyl-CpG-binding domain 2: a protective role in bladder carcinoma. Cancer. 2004 May 01; 100(9):1853-8. PMID: 15112265.
      Citations: 8     Fields:    Translation:HumansCells
    280. Lin J, Spitz MR, Wang Y, Schabath MB, Gorlov IP, Hernandez LM, Pillow PC, Grossman HB, Wu X. Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a case-control study. Carcinogenesis. 2004 Sep; 25(9):1639-47. PMID: 15117811.
      Citations: 21     Fields:    Translation:Humans
    281. Zhu Y, Spitz MR, Amos CI, Lin J, Schabath MB, Wu X. An evolutionary perspective on single-nucleotide polymorphism screening in molecular cancer epidemiology. Cancer Res. 2004 Mar 15; 64(6):2251-7. PMID: 15026370.
      Citations: 29     Fields:    Translation:HumansPHPublic Health
    282. Schabath MB, Wu X, Vassilopoulou-Sellin R, Vaporciyan AA, Spitz MR. Hormone replacement therapy and lung cancer risk: a case-control analysis. Clin Cancer Res. 2004 Jan 01; 10(1 Pt 1):113-23. PMID: 14734459.
      Citations: 65     Fields:    Translation:Humans
    283. Xu H, Wu X, Spitz MR, Shete S. Comparison of haplotype inference methods using genotypic data from unrelated individuals. Hum Hered. 2004; 58(2):63-8. PMID: 15711085.
      Citations: 8     Fields:    Translation:Humans
    284. Zheng L, Wang Y, Schabath MB, Grossman HB, Wu X. Sulfotransferase 1A1 (SULT1A1) polymorphism and bladder cancer risk: a case-control study. Cancer Lett. 2003 Dec 08; 202(1):61-9. PMID: 14643027.
      Citations: 27     Fields:    Translation:Humans
    285. Wang Y, Liang D, Spitz MR, Zhang K, Dong Q, Amos CI, Wu X. XRCC3 genetic polymorphism, smoking, and lung carcinoma risk in minority populations. Cancer. 2003 Oct 15; 98(8):1701-6. PMID: 14534887.
      Citations: 7     Fields:    Translation:Humans
    286. Wu X, Amos CI, Zhu Y, Zhao H, Grossman BH, Shay JW, Luo S, Hong WK, Spitz MR. Telomere dysfunction: a potential cancer predisposition factor. J Natl Cancer Inst. 2003 Aug 20; 95(16):1211-8. PMID: 12928346.
      Citations: 205     Fields:    Translation:HumansCells
    287. Wu X, Tortolero-Luna G, Zhao H, Phatak D, Spitz MR, Follen M. Serum levels of insulin-like growth factor I and risk of squamous intraepithelial lesions of the cervix. Clin Cancer Res. 2003 Aug 15; 9(9):3356-61. PMID: 12960122.
      Citations: 16     Fields:    Translation:Humans
    288. Wang Y, Spitz MR, Zhu Y, Dong Q, Shete S, Wu X. From genotype to phenotype: correlating XRCC1 polymorphisms with mutagen sensitivity. DNA Repair (Amst). 2003 Aug 12; 2(8):901-8. PMID: 12893086.
      Citations: 45     Fields:    Translation:HumansCells
    289. Spitz MR, Wei Q, Dong Q, Amos CI, Wu X. Genetic susceptibility to lung cancer: the role of DNA damage and repair. Cancer Epidemiol Biomarkers Prev. 2003 Aug; 12(8):689-98. PMID: 12917198.
      Citations: 102     Fields:    Translation:HumansCells
    290. Park SJ, Zhao H, Spitz MR, Grossman HB, Wu X. An association between NQO1 genetic polymorphism and risk of bladder cancer. Mutat Res. 2003 Apr 20; 536(1-2):131-7. PMID: 12694753.
      Citations: 26     Fields:    Translation:Humans
    291. Schabath MB, Spitz MR, Grossman HB, Zhang K, Dinney CP, Zheng PJ, Wu X. Genetic instability in bladder cancer assessed by the comet assay. J Natl Cancer Inst. 2003 Apr 02; 95(7):540-7. PMID: 12671022.
      Citations: 23     Fields:    Translation:HumansCells
    292. Wang Y, Spitz MR, Schabath MB, Ali-Osman F, Mata H, Wu X. Association between glutathione S-transferase p1 polymorphisms and lung cancer risk in Caucasians: a case-control study. Lung Cancer. 2003 Apr; 40(1):25-32. PMID: 12660004.
      Citations: 23     Fields:    Translation:Humans
    293. Hazra A, Chamberlain RM, Grossman HB, Zhu Y, Spitz MR, Wu X. Death receptor 4 and bladder cancer risk. Cancer Res. 2003 Mar 15; 63(6):1157-9. PMID: 12649168.
      Citations: 14     Fields:    Translation:Humans
    294. Do KA, Johnson MM, Doherty DA, Lee JJ, Wu XF, Dong Q, Hong WK, Khuri FR, Fu KK, Spitz MR. Second primary tumors in patients with upper aerodigestive tract cancers: joint effects of smoking and alcohol (United States). Cancer Causes Control. 2003 Mar; 14(2):131-8. PMID: 12749718.
      Citations: 57     Fields:    Translation:HumansCTClinical Trials
    295. Wu X, Zhao H, Wei Q, Amos CI, Zhang K, Guo Z, Qiao Y, Hong WK, Spitz MR. XPA polymorphism associated with reduced lung cancer risk and a modulating effect on nucleotide excision repair capacity. Carcinogenesis. 2003 Mar; 24(3):505-9. PMID: 12663511.
      Citations: 44     Fields:    Translation:HumansCells
    296. Zhao H, Grossman HB, Spitz MR, Lerner SP, Zhang K, Wu X. Plasma levels of insulin-like growth factor-1 and binding protein-3, and their association with bladder cancer risk. J Urol. 2003 Feb; 169(2):714-7. PMID: 12544349.
      Citations: 48     Fields:    Translation:Humans
    297. Wu X, Yu H, Makan N, Spitz MR. Assessment of insulin-like growth factors and mutagen sensitivity as predictors of lung cancer risk. Methods Mol Med. 2003; 75:279-87. PMID: 12407747.
      Citations:    Fields:    Translation:HumansCells
    298. Wu X, Schabath MB, Spitz MR. Myeloperoxidase promoter region polymorphism and lung cancer risk. Methods Mol Med. 2003; 75:121-33. PMID: 12407737.
      Citations: 3     Fields:    Translation:HumansCells
    299. Gorlova OY, Amos C, Henschke C, Lei L, Spitz M, Wei Q, Wu X, Kimmel M. Genetic susceptibility for lung cancer: interactions with gender and smoking history and impact on early detection policies. Hum Hered. 2003; 56(1-3):139-45. PMID: 14614248.
      Citations: 4     Fields:    Translation:Humans
    300. Zhu Y, Spitz MR, Strom S, Tomlinson GE, Amos CI, Minna JD, Wu X. A case-control analysis of lymphocytic chromosome 9 aberrations in lung cancer. Int J Cancer. 2002 Dec 10; 102(5):536-40. PMID: 12432559.
      Citations: 3     Fields:    Translation:HumansCells
    301. Spitz MR, Barnett MJ, Goodman GE, Thornquist MD, Wu X, Pollak M. Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort. Cancer Epidemiol Biomarkers Prev. 2002 Nov; 11(11):1413-8. PMID: 12433720.
      Citations: 26     Fields:    Translation:HumansCTClinical Trials
    302. Chang S, Wu X, Yu H, Spitz MR. Plasma concentrations of insulin-like growth factors among healthy adult men and postmenopausal women: associations with body composition, lifestyle, and reproductive factors. Cancer Epidemiol Biomarkers Prev. 2002 Aug; 11(8):758-66. PMID: 12163330.
      Citations: 17     Fields:    Translation:Humans
    303. Zhu Y, Spitz MR, Zheng YL, Hong WK, Wu X. BPDE-induced lymphocytic 3p21.3 aberrations may predict head and neck carcinoma risk. Cancer. 2002 Aug 01; 95(3):563-8. PMID: 12209748.
      Citations: 3     Fields:    Translation:HumansCells
    304. Zhu Y, Spitz MR, Hsu TC, Wu X. Genetic instability of specific chromosomes associated with a family history of cancer. Cancer Genet Cytogenet. 2002 Jul 01; 136(1):73-7. PMID: 12165456.
      Citations: 1     Fields:    Translation:HumansCells
    305. Schabath MB, Spitz MR, Hong WK, Delclos GL, Reynolds WF, Gunn GB, Whitehead LW, Wu X. A myeloperoxidase polymorphism associated with reduced risk of lung cancer. Lung Cancer. 2002 Jul; 37(1):35-40. PMID: 12057865.
      Citations: 20     Fields:    Translation:Humans
    306. Schabath MB, Spitz MR, Delclos GL, Gunn GB, Whitehead LW, Wu X. Association between asbestos exposure, cigarette smoking, myeloperoxidase (MPO) genotypes, and lung cancer risk. Am J Ind Med. 2002 Jul; 42(1):29-37. PMID: 12111688.
      Citations: 13     Fields:    Translation:HumansPHPublic Health
    307. Wu X, Lippman SM, Lee JJ, Zhu Y, Wei QV, Thomas M, Hong WK, Spitz MR. Chromosome instability in lymphocytes: a potential indicator of predisposition to oral premalignant lesions. Cancer Res. 2002 May 15; 62(10):2813-8. PMID: 12019158.
      Citations: 8     Fields:    Translation:HumansCells
    308. Wu X, Zhao H, Amos CI, Shete S, Makan N, Hong WK, Kadlubar FF, Spitz MR. p53 Genotypes and Haplotypes Associated With Lung Cancer Susceptibility and Ethnicity. J Natl Cancer Inst. 2002 May 01; 94(9):681-90. PMID: 11983757.
      Citations: 68     Fields:    Translation:HumansCells
    309. Buchholz TA, Wu X, Hussain A, Tucker SL, Mills GB, Haffty B, Bergh S, Story M, Geara FB, Brock WA. Evidence of haplotype insufficiency in human cells containing a germline mutation in BRCA1 or BRCA2. Int J Cancer. 2002 Feb 10; 97(5):557-61. PMID: 11807777.
      Citations: 25     Fields:    Translation:HumansCellsCTClinical Trials
    310. Wang Y, Spitz MR, Tsou AM, Zhang K, Makan N, Wu X. Sulfotransferase (SULT) 1A1 polymorphism as a predisposition factor for lung cancer: a case-control analysis. Lung Cancer. 2002 Feb; 35(2):137-42. PMID: 11804685.
      Citations: 26     Fields:    Translation:Humans
    311. Zhao H, Spitz MR, Gwyn KM, Wu X. Microsomal epoxide hydrolase polymorphisms and lung cancer risk in non-Hispanic whites. Mol Carcinog. 2002 Feb; 33(2):99-104. PMID: 11813302.
      Citations: 13     Fields:    Translation:HumansCells
    312. Zhang H, Spitz MR, Tomlinson GE, Schabath MB, Minna JD, Wu X. Modification of lung cancer susceptibility by green tea extract as measured by the comet assay. Cancer Detect Prev. 2002; 26(6):411-8. PMID: 12507225.
      Citations: 8     Fields:    Translation:HumansCells
    313. Zhao H, Spitz MR, Tomlinson GE, Zhang H, Minna JD, Wu X. Gamma-radiation-induced G2 delay, apoptosis, and p53 response as potential susceptibility markers for lung cancer. Cancer Res. 2001 Nov 01; 61(21):7819-24. PMID: 11691798.
      Citations: 11     Fields:    Translation:HumansCells
    314. Zhu Y, Spitz MR, Lei L, Mills GB, Wu X. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Cancer Res. 2001 Nov 01; 61(21):7825-9. PMID: 11691799.
      Citations: 55     Fields:    Translation:HumansCells
    315. Newman RA, Yang J, Raymond M, Finlay V, Cabral F, Vourloumis D, Stephens LC, Troncoso P, Wu X, Logothetis CJ, Nicolaou KC, Navone NM. Antitumor efficacy of 26-fluoroepothilone B against human prostate cancer xenografts. Cancer Chemother Pharmacol. 2001 Oct; 48(4):319-26. PMID: 11710633.
      Citations: 7     Fields:    Translation:HumansAnimalsCells
    316. Wu X, Gwyn K, Amos CI, Makan N, Hong WK, Spitz MR. The association of microsomal epoxide hydrolase polymorphisms and lung cancer risk in African-Americans and Mexican-Americans. Carcinogenesis. 2001 Jun; 22(6):923-8. PMID: 11375900.
      Citations: 17     Fields:    Translation:Humans
    317. Patrick CW, Zheng B, Wu X, Gurtner G, Barlow M, Koutz C, Chang D, Schmidt M, Evans GR. Muristerone A-induced nerve growth factor release from genetically engineered human dermal fibroblasts for peripheral nerve tissue engineering. Tissue Eng. 2001 Jun; 7(3):303-11. PMID: 11429150.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    318. Li M, Wu X, Xu XC. Induction of apoptosis in colon cancer cells by cyclooxygenase-2 inhibitor NS398 through a cytochrome c-dependent pathway. Clin Cancer Res. 2001 Apr; 7(4):1010-6. PMID: 11309352.
      Citations: 26     Fields:    Translation:HumansCells
    319. Spitz MR, Wu X, Wang Y, Wang LE, Shete S, Amos CI, Guo Z, Lei L, Mohrenweiser H, Wei Q. Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res. 2001 Feb 15; 61(4):1354-7. PMID: 11245433.
      Citations: 130     Fields:    Translation:HumansCells
    320. Buchholz TA, Wu X. Radiation-induced chromatid breaks as a predictor of breast cancer risk. Int J Radiat Oncol Biol Phys. 2001 Feb 01; 49(2):533-7. PMID: 11173151.
      Citations: 8     Fields:    Translation:HumansCells
    321. Spitz MR, Duphorne CM, Detry MA, Pillow PC, Amos CI, Lei L, de Andrade M, Gu X, Hong WK, Wu X. Dietary intake of isothiocyanates: evidence of a joint effect with glutathione S-transferase polymorphisms in lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2000 Oct; 9(10):1017-20. PMID: 11045782.
      Citations: 53     Fields:    Translation:Humans
    322. Wu X, Hudmon KS, Detry MA, Chamberlain RM, Spitz MR. D2 dopamine receptor gene polymorphisms among African-Americans and Mexican-Americans: a lung cancer case-control study. Cancer Epidemiol Biomarkers Prev. 2000 Oct; 9(10):1021-6. PMID: 11045783.
      Citations: 16     Fields:    Translation:Humans
    323. Zhang H, Buchholz TA, Hancock D, Spitz MR, Wu X. Gamma-radiation-induced single cell DNA damage as a measure of susceptibility to lung cancer: a preliminary report. Int J Oncol. 2000 Aug; 17(2):399-404. PMID: 10891553.
      Citations: 7     Fields:    Translation:HumansCells
    324. de Andrade M, Spitz MR, Wu X, Liang JC, Strom SS. Statistical models for analysis of cytogenetic biomarkers. J Investig Med. 2000 Jul; 48(4):281-6. PMID: 10916287.
      Citations:    Fields:    Translation:Humans
    325. Schabath MB, Spitz MR, Zhang X, Delclos GL, Wu X. Genetic variants of myeloperoxidase and lung cancer risk. Carcinogenesis. 2000 Jun; 21(6):1163-6. PMID: 10837005.
      Citations: 11     Fields:    Translation:HumansCells
    326. Wu X, Yu H, Amos CI, Hong WK, Spitz MR. Joint effect of insulin-like growth factors and mutagen sensitivity in lung cancer risk. J Natl Cancer Inst. 2000 May 03; 92(9):737-43. PMID: 10793110.
      Citations: 7     Fields:    Translation:HumansCells
    327. Wu X, Yu H, Amos CI, Hong WK, Spitz MR. Joint effect of insulin-like growth factors and mutagen sensitivity in lung cancer risk. Growth Horm IGF Res. 2000 Apr; 10 Suppl A:S26-7. PMID: 10984281.
      Citations: 2     Fields:    Translation:HumansCells
    328. Vulimiri SV, Wu X, Baer-Dubowska W, de Andrade M, Detry M, Spitz MR, DiGiovanni J. Analysis of aromatic DNA adducts and 7,8-dihydro-8-oxo- 2'-deoxyguanosine in lymphocyte DNA from a case-control study of lung cancer involving minority populations. Mol Carcinog. 2000 Jan; 27(1):34-46. PMID: 10642435.
      Citations: 13     Fields:    Translation:HumansCells
    329. Nersesyan AK. Re: Benzo[a]pyrene diol epoxide and bleomycin sensitivity and susceptibility to cancer of upper aerodigestive tract. J Natl Cancer Inst. 1999 Aug 04; 91(15):1334-6. PMID: 10433630.
      Citations:    Fields:    Translation:HumansCells
    330. Gu J, Spitz MR, Yang F, Wu X. Ethnic differences in poly(ADP-ribose) polymerase pseudogene genotype distribution and association with lung cancer risk. Carcinogenesis. 1999 Aug; 20(8):1465-9. PMID: 10426793.
      Citations: 2     Fields:    Translation:HumansCells
    331. Abdel-Rahman SZ, Soliman AS, Bondy ML, Wu X, El-Badawy SA, Mahgoub KG, Ismail S, Seifeldin IA, Levin B. Polymorphism of glutathione S-transferase loci GSTM1 and GSTT1 and susceptibility to colorectal cancer in Egypt. Cancer Lett. 1999 Jul 19; 142(1):97-104. PMID: 10424787.
      Citations: 7     Fields:    Translation:Humans
    332. Wu X, Kemp B, Amos CI, Honn SE, Zhang W, Walsh GL, Spitz MR. Associations among telomerase activity, p53 protein overexpression, and genetic instability in lung cancer. Br J Cancer. 1999 May; 80(3-4):453-7. PMID: 10408853; PMCID: PMC2362338.
      Citations: 3     Fields:    Translation:HumansCells
    333. Gu J, Bondy ML, Sigurdson A, Spitz MR, Hsu TC, Wu X. Three measures of mutagen sensitivity in a cancer-free population. Cancer Genet Cytogenet. 1999 Apr; 110(1):65-9. PMID: 10198626.
      Citations: 1     Fields:    Translation:HumansCells
    334. Yu H, Spitz MR, Mistry J, Gu J, Hong WK, Wu X. Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis. J Natl Cancer Inst. 1999 Jan 20; 91(2):151-6. PMID: 9923856.
      Citations: 163     Fields:    Translation:Humans
    335. Spitz MR, Wei Q, Li G, Wu X. Genetic susceptibility to tobacco carcinogenesis. Cancer Invest. 1999; 17(8):645-59. PMID: 10592771.
      Citations: 9     Fields:    Translation:HumansAnimalsCells
    336. Wu X, Zhao Y, Kemp BL, Amos CI, Siciliano MJ, Spitz MR. Chromosome 5 aberrations and genetic predisposition to lung cancer. Int J Cancer. 1998 Oct 23; 79(5):490-3. PMID: 9761118.
      Citations: 8     Fields:    Translation:HumansCells
    337. Lin H, Bondy ML, Langford LA, Hess KR, Delclos GL, Wu X, Chan W, Pershouse MA, Yung WK, Steck PA. Allelic deletion analyses of MMAC/PTEN and DMBT1 loci in gliomas: relationship to prognostic significance. Clin Cancer Res. 1998 Oct; 4(10):2447-54. PMID: 9796977.
      Citations: 18     Fields:    Translation:Humans
    338. Wu X, Gu J, Hong WK, Lee JJ, Amos CI, Jiang H, Winn RJ, Fu KK, Cooper J, Spitz MR. Benzo[a]pyrene diol epoxide and bleomycin sensitivity and susceptibility to cancer of upper aerodigestive tract. J Natl Cancer Inst. 1998 Sep 16; 90(18):1393-9. PMID: 9747870.
      Citations: 8     Fields:    Translation:HumansCells
    339. Wu X, Gu J, Amos CI, Jiang H, Hong WK, Spitz MR. A parallel study of in vitro sensitivity to benzo[a]pyrene diol epoxide and bleomycin in lung carcinoma cases and controls. Cancer. 1998 Sep 15; 83(6):1118-27. PMID: 9740076.
      Citations: 9     Fields:    Translation:HumansCells
    340. King TM, Hursting S, Contois J, Wu X, Spitz MR, Hsu TC. Correspondence re: M. T. Goodman et al., effects of beta-carotene and alpha-tocopherol on bleomycin-induced chromosomal damage. Cancer Epidemiol. Biomark. Prev., 7: 113-117, 1998. Cancer Epidemiol Biomarkers Prev. 1998 Aug; 7(8):729. PMID: 9718227.
      Citations:    Fields:    Translation:HumansCells
    341. Wu X, Gu J, Patt Y, Hassan M, Spitz MR, Beasley RP, Hwang LY. Mutagen sensitivity as a susceptibility marker for human hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev. 1998 Jul; 7(7):567-70. PMID: 9681523.
      Citations: 8     Fields:    Translation:HumansCells
    342. Wu X, Zhao Y, Honn SE, Tomlinson GE, Minna JD, Hong WK, Spitz MR. Benzo[a]pyrene diol epoxide-induced 3p21.3 aberrations and genetic predisposition to lung cancer. Cancer Res. 1998 Apr 15; 58(8):1605-8. PMID: 9563468.
      Citations: 8     Fields:    Translation:HumansCells
    343. Spitz MR, Shi H, Yang F, Hudmon KS, Jiang H, Chamberlain RM, Amos CI, Wan Y, Cinciripini P, Hong WK, Wu X. Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients. J Natl Cancer Inst. 1998 Mar 04; 90(5):358-63. PMID: 9498485.
      Citations: 49     Fields:    Translation:Humans
    344. Wu X, Amos CI, Kemp BL, Shi H, Jiang H, Wan Y, Spitz MR. Cytochrome P450 2E1 DraI polymorphisms in lung cancer in minority populations. Cancer Epidemiol Biomarkers Prev. 1998 Jan; 7(1):13-8. PMID: 9456237.
      Citations: 10     Fields:    Translation:Humans
    345. Wu X, Hsu TC, Cao S, Lee JJ, Amos CI, Spitz MR. Deletion in poly(ADP-ribose)polymerase pseudogene and lung cancer risk. Carcinogenesis. 1998 Jan; 19(1):93-8. PMID: 9472699.
      Citations: 1     Fields:    Translation:HumansCells
    346. King TM, Trizna Z, Wu X, Amos CI, Fueger RH, Fueger JJ, Fritsche HA, Hsu TC, Winn R, Spitz MR. A clinical trial to evaluate the effect of vitamin C supplementation on in vitro mutagen sensitivity. The University of Texas M. D. Anderson Clinical Community Oncology Program Network. Cancer Epidemiol Biomarkers Prev. 1997 Jul; 6(7):537-42. PMID: 9232342.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    347. Wu X, Shi H, Jiang H, Kemp B, Hong WK, Delclos GL, Spitz MR. Associations between cytochrome P4502E1 genotype, mutagen sensitivity, cigarette smoking and susceptibility to lung cancer. Carcinogenesis. 1997 May; 18(5):967-73. PMID: 9163682.
      Citations: 24     Fields:    Translation:Humans
    348. Wu X, Dave BJ, Jiang H, Pathak S, Spitz MR. Lung carcinoma patients with a family history of cancer and lymphocyte primary chromosome 9 aberrations. Cancer. 1997 Apr 15; 79(8):1527-32. PMID: 9118034.
      Citations:    Fields:    Translation:HumansCells
    349. Wu X, Hsu TC, Spitz MR. Mutagen sensitivity exhibits a dose-response relationship in case-control studies. Cancer Epidemiol Biomarkers Prev. 1996 Jul; 5(7):577-8. PMID: 8827363.
      Citations: 4     Fields:    Translation:HumansCells
    350. Wu XF, Spitz MR, Delclos GL, Connor TH, Zhao Y, Siciliano MJ, Hsu TC. Survival of cells with bleomycin-induced chromosomal lesions in the cultured lymphocytes of lung cancer patients. Cancer Epidemiol Biomarkers Prev. 1996 Jul; 5(7):527-32. PMID: 8827357.
      Citations:    Fields:    Translation:HumansCells
    351. Hsu TC, Wu X, Trizna Z. Mutagen sensitivity in humans. A comparison between two nomenclature systems for recording chromatid breaks. Cancer Genet Cytogenet. 1996 Apr; 87(2):127-32. PMID: 8625258.
      Citations: 2     Fields:    Translation:HumansCells
    352. Spitz MR, Wu X, Jiang H, Hsu TC. Mutagen sensitivity as a marker of cancer susceptibility. J Cell Biochem Suppl. 1996; 25:80-4. PMID: 9027602.
      Citations: 4     Fields:    Translation:Humans
    353. Wu X, Delclos GL, Annegers JF, Bondy ML, Honn SE, Henry B, Hsu TC, Spitz MR. A case-control study of wood dust exposure, mutagen sensitivity, and lung cancer risk. Cancer Epidemiol Biomarkers Prev. 1995 Sep; 4(6):583-8. PMID: 8547823.
      Citations: 11     Fields:    Translation:HumansPHPublic Health
    354. Jin X, Wu X, Roth JA, Amos CI, King TM, Branch C, Honn SE, Spitz MR. Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype. Carcinogenesis. 1995 Sep; 16(9):2205-8. PMID: 7554076.
      Citations: 38     Fields:    Translation:HumansCells
    355. Spitz MR, Hsu TC, Wu X, Fueger JJ, Amos CI, Roth JA. Mutagen sensitivity as a biological marker of lung cancer risk in African Americans. Cancer Epidemiol Biomarkers Prev. 1995 Mar; 4(2):99-103. PMID: 7537995.
      Citations: 9     Fields:    Translation:HumansCells
    356. Wu X, Hsu TC, Annegers JF, Amos CI, Fueger JJ, Spitz MR. A case-control study of nonrandom distribution of bleomycin-induced chromatid breaks in lymphocytes of lung cancer cases. Cancer Res. 1995 Feb 01; 55(3):557-61. PMID: 7530597.
      Citations: 4     Fields:    Translation:HumansCells
    357. Wu XF, Zhang QF. The effects of zinc on the alveolar macrophage cytotoxicity due to Ni-coal dust. Chin Med J (Engl). 1990 Sep; 103(9):754-8. PMID: 2123777.
      Citations:    Fields:    Translation:AnimalsCells
    358. Identification of six new susceptibility loci for invasive epithelial ovarian cancer. Nature Genetics. 47:164-171.
    359. Genome-wide association study confirms lung cancer susceptibility loci on chromosomes 5p15 and 15q25 in an African-American population. Lung Cancer. 98:33-42.
    360. Evaluating the ovarian cancer gonadotropin hypothesis. Gynecologic Oncology. 136:542-548.
    361. Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia. Nature Communications. 7.
    362. Germline genetic variants in the Wnt/β-catenin pathway as predictors of colorectal cancer risk. Cancer Epidemiology Biomarkers and Prevention. 25:540-546.
    363. Mitochondrial DNA content as risk factor for bladder cancer and its association with mitochondrial DNA polymorphisms. Cancer Prevention Research. 8:607-613.
    364. Assessing the genetic architecture of epithelial ovarian cancer histological subtypes. Human Genetics. 1-16.
    365. Heritability of prostate cancer. Annals of Translational Medicine. 4.
    366. Genetic susceptibility to bladder cancer risk and outcome. Personalized Medicine. 8:365-374.
    367. Metabolomics profiling in plasma samples from glioma patients correlates with tumor phenotypes. Oncotarget. 7:20486-20495.
    368. Common variation at 2q22.3 (ZEB2) influences the risk of renal cancer[Human Molecular Genetics 22,4 825-831 (2012)]Doi. Human Molecular Genetics. 22:2128.
    369. Lung cancer and wood dust exposure. Cancer Bulletin. 47:412-416.
    370. Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms. The Lancet Oncology. 18:100-111.
    371. Lung Cancer Susceptibility and Risk Assessment Models. 33-60.
    372. GPC5 rs2352028 variant and risk of lung cancer in never smokers - Authors' reply. The Lancet Oncology. 11:716.
    373. Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility. Oncotarget. 7:72381-72394.
    374. Genetic variations in apoptosis pathway and the risk of ovarian cancer. Oncotarget. 7:56737-56745.
    375. Annals of Surgical Oncology.
    376. Genetic polymorphisms in genes related to risk-taking behaviours predicting body mass index trajectory among Mexican American adolescents. Pediatric obesity.
    377. Mutational profiles reveal an aberrant TGF-β-CEA regulated pathway in colon adenomas. PLoS One. 11.
    378. Identification of Serum Markers of Esophageal Adenocarcinoma by Global and Targeted Metabolic Profiling. Clinical Gastroenterology and Hepatology. 13:1730-1737.
    379. MicroRNAs in esophageal cancer. 201-221.
    380. Personalized Risk Assessment in Never, Light, and Heavy Smokers in a prospective cohort in Taiwan. Scientific Reports. 6.
    381. Severe obesity prior to diagnosis limits survival in colorectal cancer patients evaluated at a large cancer centre. British Journal of Cancer. 114:103-109.
    382. Common genetic variation in cellular transport genes and epithelial ovarian cancer (EOC) risk. PLoS One. 10.
    383. The role of Physical activity in harm reduction among betel quid chewers from a prospective cohort of 419,378 individuals. PLoS One. 11.
    384. Identification of a novel susceptibility locus at 13q34 and refinement of the 20p12.2 region as a multi-signal locus associated with bladder cancer risk in individuals of european ancestry. Human Molecular Genetics. 25:1203-1214.
    385. Lung Cancer Susceptibility and Risk Assessment Models. 25-47.
    386. Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility loci. Human Molecular Genetics. 24:3595-3607.
    387. Polymorphisms of the centrosomal gene (FGFR1OP) and lung cancer risk. Carcinogenesis. 37:280-289.
    388. Biomarkers for Assessing Risk of Cancer.
    389. Association between genetic variants in DNA double-strand break repair pathways and risk of radiation therapy-induced pneumonitis and esophagitis in non-small cell lung cancer. Cancers. 8.
    390. Identification of genetic variants predictive of early onset pancreatic cancer through a population science analysis of functional genomic datasets. Oncotarget. 7:56480-56490.
    391. Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosome. Nature Communications. 7.
    392. Identification of lung cancer histology-specific variants applying Bayesian framework variant prioritization approaches within the TRICL and ILCCO consortia. Carcinogenesis. 36:1314-1326.
    393. MiRNA-related genetic variations associated with radiotherapy-induced toxicities in patients with locally advanced non-small cell lung cancer. PLoS One. 11.
    394. Erratum. Molecular Carcinogenesis. 27:330.
    395. Network-based integration of GWAS and gene expression identifies a HOX-centric network associated with serous ovarian cancer risk. Cancer Epidemiology Biomarkers and Prevention. 24:1574-1584.
    396. Glycemic index, glycemic load, and lung cancer risk in non-hispanic whites. Cancer Epidemiology Biomarkers and Prevention. 25:532-539.
    397. Lower mitochondrial DNA copy number in peripheral blood leukocytes increases the risk of endometrial cancer. Molecular Carcinogenesis.
    398. Genetic Risk Can Be Decreased. EBioMedicine. 11:219-226.
    399. Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer. Nature Communications. 6.
    400. Predictors of health-related quality of life and association with survival may identify colorectal cancer patients at high risk of poor prognosis. Quality of Life Research. 1-12.
    401. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer. Oncotarget. 7:69097-69110.
    402. Multilevel-analysis identify a cis-expression quantitative trait locus associated with risk of renal cell carcinoma. Oncotarget. 6:4097-4109.
    403. The relationship between Native American Ancestry, body mass index and diabetes risk among Mexican-Americans. PLoS One. 10.
    404. The role of PI3K/PTEN/AKT/mTOR genetic variation in clinical outcomes following chemoradiotherapy for esophageal cancer. American Journal of Hematology/ Oncology. 8.
    405. Racial/ethnic disparities in breast cancer risk. Breast Diseases. 24:212-216.
    406. Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk. Genetic Epidemiology. 39:689-697.
    407. Mosaic loss of chromosome Y is associated with common variation near TCL1A. Nature Genetics. 48:563-568.
    408. Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes. Human Molecular Genetics. 25:1663-1676.
    409. Genomic DNA hypomethylation and risk of renal cell carcinoma. Clinical Cancer Research. 22:2074-2082.
    410. Physical activity to overcome the adversity of widowhood. Medicine (United States). 95.
    411. Association between GSTM1 copy number, promoter variants and susceptibility to urinary bladder cancer. International Journal of Molecular Epidemiology and Genetics. 3:228-236.
    412. Exercise and life expectancy - Authors' reply. The Lancet. 379:800-801.
    413. Shared genetics underlying epidemiological association between endometriosis and ovarian cancer. Human Molecular Genetics. 24:5955-5964.
    414. Erratum. Nature Genetics. 41:1156.
    415. Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma. 1233-1238.
    416. PALB2, CHEK2 and ATM rare variants and cancer risk. Journal of Medical Genetics.
    417. Genetic variants in the fibroblast growth factor pathway as potential markers of ovarian cancer risk, therapeutic response, and clinical outcome. Clinical Chemistry. 60:222-232.
    418. Erratum. Nature Genetics. 41:1156.
    419. Cancer of the Lung.
    420. Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types. Journal of the National Cancer Institute. 107.
    421. Different dietary patterns and reduction of lung cancer risk. Scientific Reports. 6.
    422. Novel fluorescence in situ hybridization-based definition of bacille Calmette-Guérin (BCG) failure for use in enhancing recruitment into clinical trials of intravesical therapies. BJU International.
    423. Erratum. Cancer. 120:3264.
    424. MicroRNA profiling in clear cell renal cell carcinoma tissues potentially links tumorigenesis and recurrence with obesity. British Journal of Cancer. 116:77-84.
    425. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. Gynecologic Oncology. 141:386-401.
    426. Genetic variants of the Wnt signaling pathway as predictors of aggressive disease and reclassification in men with early stage prostate cancer on active surveillance. Carcinogenesis. 37:965-971.
    427. Mitochondrial DNA copy number in peripheral blood leukocytes and the aggressiveness of localized prostate cancer. Oncotarget. 6:41988-41996.
    428. Variant alleles of the D2 dopamine receptor gene and obesity. Nutrition Research. 20:371-380.
    429. Susceptibility loci of CNOT6 in the general mRNA degradation pathway and lung cancer risk-A re-analysis of eight GWASs. Molecular Carcinogenesis.
    430. International cancer seminars. Annals of Oncology. 27:1382-1385.
    431. Genetic variants in telomere-maintenance genes are associated with ovarian cancer risk and outcome. Journal of Cellular and Molecular Medicine.
    WU's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (808)
    Explore
    _
    Co-Authors (146)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _